Podcasts about lancet psychiatry

¿De verdad crees que un solo ciclo de esteroides no te va a hacer daño?La ciencia es clara: con una sola vez puede ser suficiente para alterar tu cuerpo y tu mente para siempre.En este video te explico qué son realmente los esteroides anabolizantes, cómo actúan en tu organismo y por qué pueden ser una trampa irreversible.Desde efectos hormonales hasta daños en el corazón, el hígado o incluso la aparición de cáncer: todo lo que debes saber antes de caer en la tentación.

ADHD Meds: Are They Safe Long-Term? What the World's Largest Study Just Told Us You’re sitting in the paediatrician’s office, staring at a tiny tablet in your hand, wondering if giving it to your child makes you a bad parent—or a better one. Sound familiar? In this solo episode, Jane breaks down the world’s biggest ADHD medication study—just published in The Lancet Psychiatry—and unpacks what it really means for neurodivergent families. We’re talking hard data, real side effects, long-term unknowns, and the emotional load mums carry when we’re asked to medicate our kids. This episode is your crash course in science and lived experience. No moral panic, no TikTok nonsense. Just the facts—and how they actually apply to real-life parenting.

Un nouvel épisode du Pharmascope est disponible… Et on s'attaque encore aux cannabinoïdes! Dans cette deuxième partie, Nicolas, Isabelle, Olivier et un invité discutent de douleurs non-neuropathiques, d'autres indications potentielles des cannabinoïdes et de cannabinoïdes topiques.  Les objectifs pour cet épisode sont les suivants: Discuter des données d'efficacité des cannabinoïdes pour les douleurs non-neuropathiques Discuter des données d'efficacité des cannabinoïdes pour d'autres indications que le traitement de la douleur Discuter des cannabinoïdes topiques dans le traitement de la douleur Ressources pertinentes en lien avec l'épisode  Société québécoise de la douleur Häuser W, Welsch P, Radbruch L, Fisher E, Bell RF, Moore RA. Cannabis-based medicines and medical cannabis for adults with cancer pain. Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD014915. Filippini G, Minozzi S, Borrelli F, Cinquini M, Dwan K. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Cochrane Database Syst Rev. 2022 May 5;5(5):CD013444. Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD009464. Kafil TS, Nguyen TM, MacDonald JK, Chande N. Cannabis for the treatment of Crohn's disease. Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD012853. Kafil TS, Nguyen TM, MacDonald JK, Chande N. Cannabis for the treatment of ulcerative colitis. Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD012954. Black N et coll. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019 Dec;6(12):995-1010. Coelho CF et coll. The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials. Life (Basel). 2024 Oct 25;14(11):1373. Bahji A, Meyyappan AC, Hawken ER. Efficacy and acceptability of cannabinoids for anxiety disorders in adults: A systematic review & meta-analysis. J Psychiatr Res. 2020 Oct;129:257-264. Rodas JD, George TP, Hassan AN. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters. J Clin Psychiatry. 2024 Feb 14;85(1):23r14862 Bhagavan C et coll. Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis. CNS Drugs. 2020 Dec;34(12):1217-1228. Wang M et coll. Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: a double-blind, placebo-controlled, randomized, crossover study. J Clin Sleep Med. 2025 Jan 1;21(1):69-80. Joshi N, Mariam H, Kamath A. Cannabinoids for the Treatment of Glaucoma: A Review. Med Cannabis Cannabinoids. 2024 Sep 16;7(1):183-192. Boylan PM, Santibañez M, Thomas J, Weeda E, Noel ZR, Caballero J. Cannabinoids for obstructive sleep apnea: A systematic review. Pharmacotherapy. 2024 Nov;44(11):880-891. Hunter D et coll.Synthetic transdermal cannabidiol for the treatment of knee pain due to osteoarthritis. Osteoarthritis and Cartilage. 2018. 26. S26.

Sophia Davis, senior editor at The Lancet Psychiatry, discusses research on a new digital therapy for borderline personality disorder with Philip Klein from the University of Lubeck, Germany. This episode delves into the core experiences of borderline personality disorder, the innovative schema therapy-based digital intervention, and the results from the new study. Learn about the effectiveness, safety, and potential of digital therapies to affect mental health treatment, and their potential to reach more patients.Read the full article:https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00063-X/fulltext?dgcid=buzzsprout_tlv_podcast_15-04-25_lanpsyContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Die Themen in den Wissensnachrichten: +++ Zu viele Kanäle im Homeoffice machen Druck +++ Laser sollen im Weltraum gegen Müll helfen +++ Auswandern macht erstmal zufriedener +++**********Weiterführende Quellen zu dieser Folge:Digitaler Arbeitsplatz, Frontiers in Organizational Psychology, 2-2024Start-ups mit Lasern gegen Weltraumschrott, 17.12.2024Auswandern erhöht Lebenszufriedenheit, BiB, 18.12.2024Schmetterling durch Erdbeben ausgestorben, Plos One, 20.11.2024ADHS bei Erwachsenen, The Lancet Psychiatry, Januar 2025Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok auf&ab , TikTok wie_geht und Instagram .

Gehört ihr zu den Menschen, die morgens aus dem Bett hüpfen und auf den neuen Tag mit einem “Ja, ich schaffe das!” blicken? Oder seid ihr doch eher Leute, die im Geiste erstmal durchgehen, was heute alles schwierig wird und schiefgehen kann? Leon und Atze sprechen über das Vertrauen in die eigenen Fähigkeiten: Was bewirkt es und wie können wir mehr davon bekommen? Aber Vorsicht: Zu viel Vertrauen in sich selbst kann auch schaden! Fühlt euch gut betreut Leon & Atze Start ins heutige Thema: 13:52 min. VVK Münster 2025: https://betreutes-fuehlen.ticket.io/ Instagram: https://www.instagram.com/leonwindscheid/ https://www.instagram.com/atzeschroeder_offiziell/ Der Instagram Account für Betreutes Fühlen: https://www.instagram.com/betreutesfuehlen/ Mehr zu unseren Werbepartnern findet ihr hier: https://linktr.ee/betreutesfuehlen Tickets: Atze: https://www.atzeschroeder.de/#termine Leon: https://leonwindscheid.de/tour/ Es geht am Anfang um Suizid und Atze spricht eine Nummer an, wo man Hilfr kriegt. Die lautet 0800 111 0 111. Noch mehr Hilfsangebote gibts hier: https://www.suizidprophylaxe.de/hilfsangebote/hilfsangebote/ Wichtige Quellen: Online-Studie von Eva Asselmann zum Mitmachen: (Für Erwachsene zwischen 18 und 30 Jahren) https://selftie-studie.de/ Review zur Frage, wie sich Selbstwirksamkeit auf Körper und Geist auswirkt: Schönfeld, P. et al. (2017). Costs and benefits of self-efficacy: Differences of the stress response and clinical implications. Neurosci Biobehav Rev. 75:40-52. Doi: 10.1016/j.neubiorev.2017.01.031 https://www.sciencedirect.com/science/article/abs/pii/S0149763416302718 Review zu verschiedenen Interventionen: Ashford, S. et al. (2010). What is the best way to change self-efficacy to promote lifestyle and recreational physical activity? A systematic review with meta-analysis. Br J Health Psychol. 15(2):265-288. Doi: 10.1348/135910709X461752 https://bpspsychub.onlinelibrary.wiley.com/doi/epdf/10.1348/135910709X461752 Meta-Analyse zum Zusammenspiel von Erfolgserfahrungen und Selbstwirksamkeitserwartung: Talsma, K. et al. (2018). I believe, therefore I achieve (and vice versa): A meta-analytic cross-lagged panel analysis of self-efficacy and academic performance. Learn Ind Diff. 61:136-150. Doi: 10.1016/j.lindif.2017.11.015 https://www.sciencedirect.com/science/article/abs/pii/S104160801730211X Die ARD-Doku, die Leon empfiehlt https://www.ardmediathek.de/video/ard-wissen/mein-koerper-meine-brueste-was-soll-der-hype/swr/Y3JpZDovL3N3ci5kZS9hZXgvbzIxNDU3MDg Der Bericht der 50 Fachleute: McGorry, P. D., Mei, C., Dalal, N., Alvarez-Jimenez, M., Blakemore, S. J., Browne, V., ... & Killackey, E. (2024). The Lancet Psychiatry Commission on youth mental health. The Lancet Psychiatry, 11(9), 731-774. Der Bericht in der ZEIT: https://www.zeit.de/2024/36/psychische-stoerungen-kinder-jugendliche-eltern-erkennen Mögliche Ursache der psy. Probleme bei Kindern: Gray, P., Lancy, D. F., & Bjorklund, D. F. (2023). Decline in independent activity as a cause of decline in children's mental well-being: summary of the evidence. The Journal of pediatrics, 260. Redaktion: Stefanie Uhrig Produktion: Murmel Productions

Dive into the fascinating world of virology as we welcome Nobel Prize-winning virologist Dr. Michael Houghton on this episode of Discovery Matters. We explore Dr. Houghton's groundbreaking work in identifying the hepatitis C virus (HCV) and his enduring quest to combat this global health threat. From the monumental discovery of HCV in 1982 to the revolutionary diagnostic tests that nearly eradicated transfusion-related hepatitis C by the mid-1990s, Dr. Houghton provides an engaging and insightful journey through decades of scientific innovation. Show notes Richard D Roberts, Patrick C Kyllonen, ‘Morningness–eveningness and intelligence: early to bed, early to rise will likely make you anything but wise!' Personality and Individual Differences, Volume 27, Issue 6, 1999. https://doi.org/10.1016/S0191-8869(99)00054-9. Taquet, MaximeLone, Nazir et al. ‘Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.' The Lancet Psychiatry, Volume 11, Issue 9. https://doi.org/10.1016/S2215-0366(24)00214-1

In this week's episode of the 3 Pillars Podcast we will be discussing suicide prevention and why YOU MATTER. September is National Suicide Prevention Month – a time to remember the lives lost to suicide, acknowledge the millions more who have experienced suicidal thoughts, and the many individuals, families and communities that have been impacted by suicide. It's also a time to raise awareness about suicide prevention and share messages of hope. SUBSCRIBE TO THE NEW PODCAST CHANNEL HERE: https://www.youtube.com/@3PillarsPodcast God bless you all. Jesus is King. “But God commendeth his love toward us, in that, while we were yet sinners, Christ died for us.” ‭‭Romans‬ ‭5‬:‭8‬ ‭KJV‬‬ I appreciate all the comments, topic suggestions, and shares! Find the "3 Pillars Podcast" on all major platforms. For more information, visit the 3 Pillars Podcast website: https://3pillarspodcast.wordpress.com/ Don't forget to check out the 3 Pillars Podcast on Goodpods and share your thoughts by leaving a rating and review: https://goodpods.app.link/3X02e8nmIub Please Support Veteran's For Child Rescue: https://vets4childrescue.org/ Stay connected with Joe Russiello and the "Sword of the Spirit" Podcast: https://www.swordofthespiritpodcast.com/ Join the conversation: #3pillarspodcast Resources for Those in Need If you or someone you know is struggling with suicidal thoughts or mental health challenges, it is important to seek help immediately. The following resources offer confidential support: National Suicide Prevention Lifeline: 1-800-273-TALK (8255) or 988 Veterans Crisis Line: 1-800-273-8255 (Press 1) Crisis Text Line: Text HOME to 741741 Military OneSource: 1-800-342-9647 Safe Call Now: 1-206-459-3020 American Foundation for Suicide Prevention (AFSP): www.afsp.org References 1) Joiner, T. E. (2005). Why People Die by Suicide. Harvard University Press.This book presents the Interpersonal Theory of Suicide, exploring key psychological constructs like perceived burdensomeness and thwarted belongingness that contribute to suicidal behavior. 2) Van Orden, K. A., Witte, T. K., Cukrowicz, K. C., Braithwaite, S. R., Selby, E. A., & Joiner, T. E. (2010). The interpersonal theory of suicide. Psychological Review, 117(2), 575-600.This article provides a comprehensive overview of the interpersonal theory of suicide and outlines empirical support for its key components. 3) Sher, L., & Vilens, A. (2019). Suicidal Behavior in Military Veterans: A Review of Risk Factors and Prevention Strategies. International Journal of Environmental Research and Public Health, 16(21), 4112.This review focuses on suicide in military veterans, identifying key risk factors such as combat exposure and trauma, while discussing prevention strategies tailored to this population. 4) Bryan, C. J., & Rudd, M. D. (2018). Suicide Prevention in Military and Veteran Populations. Oxford University Press.This book explores the unique factors contributing to suicide among military personnel and veterans and provides evidence-based approaches to suicide prevention. 5) Zalsman, G., Hawton, K., Wasserman, D., van Heeringen, K., Arensman, E., Sarchiapone, M., & Courtet, P. (2016). Suicide prevention strategies revisited: 10-year systematic review. The Lancet Psychiatry, 3(7), 646-659.This systematic review examines global suicide prevention strategies, discussing the effectiveness of various interventions, including access to mental health care and means restriction. --- Support this podcast: https://podcasters.spotify.com/pod/show/chase-tobin/support

The Lancet Psychiatry Commission on youth mental health

In this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. David Taylor is the Director of Pharmacy and Pathology at Maudsley Hospital and a Professor of Psychopharmacology at King's College in London. He is also the editor-in-chief of the journal Therapeutic Advances in Psychopharmacology. Beyond academia, he contributes significantly to public health policy as a member of the United Kingdom's Department of Transport expert panel that introduced drug-driving regulations. He is also a current member of the UK government's Advisory Council on the Misuse of Drugs and is the only pharmacist to have been made an honorary fellow of the Royal College of Psychiatrists. David is the lead author of the Maudsley Prescribing Guidelines, a role he has held since their inception in 1993. The Maudsley Prescribing Guidelines have achieved significant success, with over 300,000 copies sold across 14 editions and translations into 12 languages. David has also authored 450 clinical papers published in prominent journals such as The Lancet, BMJ, British Journal of Psychiatry, and Journal of Clinical Psychiatry. His work has been cited over 25,000 times. Mark Horowitz is a clinical research fellow in psychiatry at the National Health Service (NHS) in London. He is a Visiting Lecturer in Psychopharmacology at King's College London and an Honorary Clinical Research Fellow at University College London, in addition to being a trainee psychiatrist. Mark holds a PhD from the Institute of Psychiatry, Psychology, and Neuroscience at King's College London, specializing in the neurobiology of depression and antidepressant action. He is the lead author of the Maudsley Deprescribing Guidelines and an associate editor of Therapeutic Advances in Psychopharmacology. Mark co-authored the recent Royal College of Psychiatry's guidance on stopping antidepressants, and his work has informed the recent NICE guidelines on the safe tapering of psychiatric medications, including antidepressants, benzodiazepines, and z-drugs. He has collaborated with the NHS to develop national guidance for safe deprescribing for clinicians and has been commissioned by Health Education England to prepare a teaching module on how to safely stop antidepressants. Mark has published several papers on safe approaches to tapering psychiatric medications, with contributions in The Lancet Psychiatry, JAMA Psychiatry, and Schizophrenia Bulletin. His interest lies in rational psychopharmacology and the deprescribing of psychiatric medications, which is deeply informed by his personal experiences of the challenges associated with coming off psychiatric medications. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2024. Produced by James Moore https://www.jmaudio.org

Durante algún tiempo la ciencia anduvo detrás de la investigación en el cerebro sobre dónde y cómo funcionaban los/el centro del placer. Algunos científicos estuvieron cerca de descubrirlo pero en algunos famosos casos, el motivo por el cual justificaban su investigación alteraron los resultados, aunque en realidad nunca fueron suficientemente concluyentes. Incluso las agencias de inteligencia de algunos países se centraron en ello, con el objetivo de controlar a los sujetos o la población. Hoy en día parece que esta investigación se abandonó, pero como siempre podría ser que se continúe en el más absoluto secreto. ¿Existe un Centro del Placer en el Cerebro? El concepto del “centro del placer” en el cerebro ha capturado la imaginación de científicos, filósofos y el público general durante décadas. ¿Es posible que una región específica del cerebro sea responsable de las sensaciones de placer? La respuesta es más compleja y matizada de lo que podría parecer a primera vista. 1. Orígenes del Concepto: Experimentos Pioneros En los años 50, los investigadores James Olds y Peter Milner descubrieron áreas del cerebro que, al ser estimuladas eléctricamente, producían respuestas de comportamiento asociadas con el placer en ratas de laboratorio. Olds y Milner implantaron electrodos en el cerebro de estas ratas y notaron que los animales repetían conductas dirigidas a la autoadministración de la estimulación eléctrica. Estos hallazgos llevaron a la identificación del sistema de recompensa del cerebro, un conjunto de estructuras cerebrales que parecía mediar el placer y la motivación . 2. El Sistema de Recompensa: Un Mosaico de Placer El sistema de recompensa incluye varias regiones clave, entre ellas: • Área Tegmental Ventral (ATV): Produce dopamina, un neurotransmisor crucial en la experiencia del placer. • Núcleo Accumbens: Recibe señales dopaminérgicas del ATV y está implicado en la evaluación de recompensas y la motivación. • Amígdala: Procesa la emoción y puede influir en la experiencia del placer. • Corteza Prefrontal: Involucrada en la toma de decisiones y la regulación de impulsos relacionados con recompensas. Este sistema forma una red de estructuras interconectadas, más que un único “centro del placer”. La dopamina juega un papel central, no solo en la percepción del placer sino también en la anticipación de recompensas . 3. Más Allá de la Dopamina: Una Perspectiva Multifactorial Aunque la dopamina ha sido tradicionalmente asociada con el placer, investigaciones recientes sugieren que su papel es más complejo. La dopamina parece estar más relacionada con la motivación y el aprendizaje de recompensas que con la sensación directa de placer . En otras palabras, la dopamina ayuda a predecir y buscar recompensas, pero el placer experimentado podría depender de otras sustancias neuroquímicas, como la serotonina y los opioides endógenos. 4. Placer, Motivación y Conducta: Un Entrelazado Complejo El placer no es una experiencia monolítica; varía según el contexto, la persona y la situación. La distinción entre “querer” (motivación) y “gustar” (placer) es fundamental en la neurociencia actual. Los estudios muestran que las áreas cerebrales que mediatizan el “querer” (como el núcleo accumbens) pueden diferenciarse de aquellas que mediatizan el “gustar” (como la corteza insular). Esta dicotomía subraya que el placer y la motivación, aunque relacionados, no son sinónimos . 5. Aplicaciones y Repercusiones Clínicas La comprensión del sistema de recompensa tiene implicaciones prácticas significativas. Trastornos como la depresión y la adicción están estrechamente relacionados con disfunciones en estas vías. Por ejemplo, la depresión puede implicar una hipofunción del sistema de recompensa, resultando en una incapacidad para experimentar placer, conocida como anhedonia . La adicción, por otro lado, puede estar marcada por una hiperactividad dopaminérgica, llevando a una búsqueda compulsiva de recompensas a pesar de las consecuencias negativas. 6. Nuevas Fronteras en la Investigación del Placer La investigación sobre el placer cerebral sigue avanzando. Las técnicas de neuroimagen y la genética están revelando detalles más precisos sobre cómo diferentes regiones y neurotransmisores interactúan para generar la experiencia de placer. Estudios recientes han comenzado a explorar cómo los factores sociales y ambientales modulan el sistema de recompensa, proporcionando una comprensión más holística de cómo el cerebro procesa el placer. 7. Conclusión: Un Viaje Multifacético Aunque la idea de un único “centro del placer” es atractiva, la realidad es que el placer es el resultado de una compleja interacción entre múltiples áreas cerebrales y sistemas neuroquímicos. En lugar de un solo centro, tenemos un sistema de recompensa que integra la anticipación, la experiencia y la motivación relacionadas con las recompensas. Esta red de estructuras y mecanismos es fundamental para nuestra comprensión del comportamiento humano y la búsqueda de la felicidad. El conocimiento sobre el sistema de recompensa y el placer cerebral es un campo dinámico y en evolución, prometiendo nuevas perspectivas sobre cómo experimentamos el mundo y buscamos la satisfacción en nuestras vidas. Referencias 1. Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419. 2. Schultz, W. (2015). Neuronal Reward and Decision Signals: From Theories to Data. Physiological Reviews, 95(3), 853-951. 3. Berridge, K. C., & Kringelbach, M. L. (2015). Pleasure systems in the brain. Neuron, 86(3), 646-664. 4. Kelley, A. E., & Berridge, K. C. (2002). The neuroscience of natural rewards: relevance to addictive drugs. Journal of Neuroscience, 22(9), 3306-3311. 5. Der-Avakian, A., & Markou, A. (2012). The neurobiology of anhedonia and other reward-related deficits. Trends in Neurosciences, 35(1), 68-77. 6. Volkow, N. D., & Morales, M. (2015). The Brain on Drugs: From Reward to Addiction. Cell, 162(4), 712-725. 7. Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760-773. 8. Nestler, E. J., & Luscher, C. (2019). The neurobiology of drug addiction: a neurocircuit perspective. Neuropharmacology, 76, 124-133. Otros temas en el programa: 40:55 John Williams 1:34:44 La cultura de la inmediatez 1:47:33 Carreras de Cuadrigas No soy el Señor Monstruo - Capítulo 15 Puedes leer más y comentar en mi web, en el enlace directo: https://luisbermejo.com/el-centro-del-placer-zz-podcast-05x47/ Puedes encontrarme y comentar o enviar tu mensaje o preguntar en: WhatsApp: +34 613031122 Paypal: https://paypal.me/Bermejo Bizum: +34613031122 Web: https://luisbermejo.com Facebook: https://www.facebook.com/ZZPodcast/ X (twitters): https://x.com/LuisBermejo y https://x.com/zz_podcast Instagrams: https://www.instagram.com/luisbermejo/ y https://www.instagram.com/zz_podcast/ Canal Telegram: https://t.me/ZZ_Podcast Canal WhatsApp: https://whatsapp.com/channel/0029Va89ttE6buMPHIIure1H Grupo Signal: https://signal.group/#CjQKIHTVyCK430A0dRu_O55cdjRQzmE1qIk36tCdsHHXgYveEhCuPeJhP3PoAqEpKurq_mAc Grupo Whatsapp: https://chat.whatsapp.com/FQadHkgRn00BzSbZzhNviThttps://chat.whatsapp.com/BNHYlv0p0XX7K4YOrOLei0

In this episode of the Data Malarkey podcast, data storyteller Sam Knowles is joined by Sir Simon Baron-Cohen, Professor of Developmental Psychopathology at the University of Cambridge, where he also runs the Autism Research Centre. Simon has been working in the field of autism for approaching 40 years and is one of the world's leading authorities on the subject.   Since the mid-1980s, the research he's led and undertaken has led him to advance several different, complementary theories of the condition including: the mind-blindness theory, the prenatal sex steroid theory, and the empathising-systemising theory of autism and typical sex differences.   Some corners of autism research have a somewhat shady and disreputable reputation for their misuse of data; for drawing conclusions about the general population from tiny sample sizes that the data could not warrant. Indeed, it was in the wake of the MMR scandal that the charity Sense About Science was founded in the early 2000s – to encourage researchers to present their findings responsibly and the media to report them responsibly – and Sense About Science's director, Tracey Brown, was a recent guest on Data Malarkey.   By contrast with the shady stuff, Simon's research has been a shining light of empiricism and evidence-based, data-driven truth, with sample sizes sometimes in the tens or hundreds of thousands. His 2018, empathising-systemising study famously collected data from 36,000 autistic people and 600,000 non-autistic people.   Described by the medical journal The Lancet as “a man with extraordinary knowledge … his passionate advocacy for a more tolerant, diverse society, where difference is respected and cultivated, reveals a very human side to his science” it is our honour to welcome Simon to Data Malarkey. A very fitting, very high-profile end to Season Five, a season bookended by two great Cambridge minds, as we started with Professor Sir David Spiegelhalter.   To secure Simon as a guest on Data Malarkey, I'm delighted to say I had to drop my son Max's name. At the time of recording, Max had recently hosted Simon at an excellent event run by the recently-reborn Cambridge Psychology Society, of which Max is now President. At the university, he is studying Psychological & Behavioural Sciences. #proudfather   EXTERNAL LINKS Profile of Simon on The Lancet – Psychiatry site https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(15)00461-7/fulltext   The Autism Research Centre https://www.autismresearchcentre.com   The extraordinary output of 750+ articles from the Autism Research Centre on PubMed https://pubmed.ncbi.nlm.nih.gov/?term=simon+baron-cohen&sort=date   Auticon, the social enterprise on a mission to improve the employment prospects of neurodivergent people, whose board Simon advises https://auticon.com/uk/     To find out what kind of data storyteller you are, complete our data storytelling scorecard at https://data-storytelling.scoreapp.com. It takes just two minutes, and we'll send you your own personalised scorecard which tells you what kind of data storyteller you are.  

Antidepressant Discontinuation Insights**: A recent Lancet Psychiatry review reveals that only 1 in 6 or 7 patients will experience symptoms upon stopping antidepressants, with severe symptoms occurring in just 1 in 35 patients. The importance of tapering off medication rather than stopping abruptly is emphasised, aligning with official health guidelines.Heart Regeneration Research**: Massachusetts General Hospital uncovers groundbreaking differences in scar tissue between zebrafish and mammals, potentially opening new avenues for heart attack treatments. Targeting the enzyme lysol hydroxylase two could prevent permanent scarring, revolutionising the way we treat heart attacks and fibrotic diseases.Community-Led Child Support**: Insights from the Lancet underline the critical role of culturally sensitive community-led child support systems. Empowering communities to take charge of child support can prevent future tragedies and create healthier environments for our children.

Some of the most egregious harms have been done in the name of “help,” and this is especially true when it comes to forced psychiatric interventions. Investigative journalist, Rob Wipond illuminates the systemic harms of the psychiatric system after experiencing his father attempt to get help and instead of care, be met with coercion and force. As many find out, this is an all too common story. The evidence that psychiatric detention is beneficial to people is lacking, yet rates continue to dramatically rise. From mental health laws and policies, to corruption in pharmaceutical companies, and even political organizations lobbying for more control, all grease the wheels of power and injustice. In this episode we discuss: the politics of forced psychiatric treatment and why it is harmful how the evidence on forced treatment is systematically hidden the ins and out of mental health laws why there's a higher suicide risk in the weeks after psychiatric hospitalization how giving people the label of ‘lacking insight' is dangerous and false several alternative interventions and why we need more advocates advice for family members the cultural shift that's needed Rob Wipond is a freelance investigative journalist who writes frequently about the interfaces between psychiatry, civil rights, community issues, policing, surveillance and privacy, and social change. His articles have been nominated for seventeen magazine and journalism awards in science, law, business, and community issues, and he's the author of the book Your Consent is Not Required: The Rise in Psychiatric Detentions, Forced Treatment, and Abusive Guardianships. Links Rob's Website: https://robwipond.com/about Book: Your Consent is not Required: https://robwipond.com/your-consent-is-not-required Socials: https://twitter.com/robwipond https://www.facebook.com/RobWipondAuthor https://www.youtube.com/user/robwipond Resources: US rates of committment: Lee, Gi and David Cohen. “Incidences of Involuntary Psychiatric Detentions in 25 U.S. States.” Psychiatric Services 72, no. 1 (January 1, 2021). https://doi.org/10.1176/appi.ps.201900477 European rates of commitment: Sheridan Rains, Luke. “Variations in Patterns of Involuntary Hospitalisation and in Legal Frameworks: An International Comparative Study.” Lancet Psychiatry 6, no. 5 (May 2019). https://doi.org/10.1016%2 FS2215-0366(19)30090-2 Suicidality after hospitalization: Whitaker, Robert. “Suicide in the Age of Prozac.” Mad in America (August 6, 2018). https://www.madinamerica.com/2018/08/suicide-in-the-age-ofprozac/ & Simons, Peter. “Involuntary Hospitalization Increases Risk of Suicide.” Mad in America (June 24, 2019). https://www.madinamerica. com/2019/06/involuntary-hospitalization-increases-risk-suicide-study-finds/ United Nations statement: https://www.ohchr.org/en/statements/2020/10/statement-mr-dainius-puras-special-rapporteur-right-everyone-enjoyment-highest Find all notes, research, and resources list on Rob's Website Become a member of the Institute for the Development of Human Arts: ⁠www.idha-nyc.org⁠ Sessions & Information about the host: ⁠⁠JazmineRussell.com⁠⁠ Disclaimer: The DEPTH Work Podcast is for educational and entertainment purposes only. Any information on this podcast in no way to be construed or substituted as psychological counseling, psychotherapy, mental health counseling, or any other type of therapy or medical advice.

Drew Ramsey, MD is a pioneer in the field of mental health. He is a board-certified psychiatrist, best-selling author, & mental health advocate. His work focuses on Nutritional Psychiatry and optimizing mental fitness. He's been featured by The New York Times, The Wall Street Journal, Lancet Psychiatry, The Today Show, BBC, and NPR and he has given several TEDx talks. His podcast empowers listeners with the latest, actionable information to optimize mental fitness and help navigate the complex world of mental health. So, how do you optimize mental health and mental fitness? Join us to find out! Watch on YouTube: https://www.youtube.com/channel/UCEMEq_ZuV1bfIauVa2p2KEg Listen on Audio Platforms:  https://podcasters.spotify.com/pod/show/dr-drew-ramsey-podcast  Connect with Dr. Drew Ramsey:  Instagram: https://www.instagram.com/drewramseymd/  Website: https://drewramseymd.com

In this episode, we discuss the impact of coercive control on mental health. We explore how and why coercive control impacts mental health, as well as what resources are available for supporting the mental health recovery of survivors of coercive control.   To help us we welcome special guest Prof. Louise Howard. Louise is Professor Emerita in Women's Mental Health at King's College London. Her research has focused on violence, abuse and mental health as well as perinatal mental health. To find out more about Louise's work click here. You can click the links below to access some of the resources we talk about in this episode, as well as some additional resources from our guest: Resources: LARA VP - A resource to help mental health professionals identify and respond to Domestic Violence and Abuse: https://www.kcl.ac.uk/mental-health-and-psychological-sciences/research/lara-vp-download-form Books: Bessel van der Kolk. The Body keeps the score: ⁠https://www.besselvanderkolk.com/resources/the-body-keeps-the-score⁠ Evan Starks. Coercive Control. How Men Entrap Women in Personal Life: ⁠https://global.oup.com/academic/product/coercive-control-9780197639986?cc=us&lang=en&⁠  Herman J. Trauma and Recovery: ⁠https://psycnet.apa.org/record/2015-30136-000 Academic Papers: Dokkedahl, S.B., Kirubakaran, R., Bech-Hansen, D. et al. The psychological subtype of intimate partner violence and its effect on mental health: a systematic review with meta-analyses. Syst Rev 11, 163 (2022). https://doi.org/10.1186/s13643-022-02025-z Keynejad, R., Hanlon, C., Howard, L. (2020). Psychological interventions for common mental disorders in women experiencing intimate partner violence in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet Psychiatry, Volume 7, Issue 2, 173 – 190 https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30510-3/fulltext  Oram S et al. Lancet Psychiatry Commission on intimate partner violence and mental health: advancing mental health services, research, and policy. Lancet Psychiatry. 2022 Jun;9(6):487-524. doi: 10.1016/S2215-0366(22)00008-6. The main systematic review we discuss during the episode: Lohmann, S., Cowlishaw, S., Ney, L., O'Donnell, M., & Felmingham, K. (2024). The Trauma and Mental Health Impacts of Coercive Control: A Systematic Review and Meta-Analysis. Trauma, Violence, & Abuse, 25(1), 630-647. https://doi.org/10.1177/15248380231162972

We're baaaack with episode 2 of Turn-Based Besties, and today we are diving right into our top three games of 2023. Note, these will be our personal favorite games we played in 2023, not necessarily games that were released in 2023 (because we know DJ likes his retro and indie games). We will also be trying out a new segment called "Medical Moment" with Sam, as he discusses video games and certain illness or conditions that occur with a character. Disclaimer: we do not provide medical diagnoses, recommendations, treatment, etc. Here's a brief reference list for you nerds out there ;) References:  Loewenstein, Richard. (2023). Dissociative amnesia: Epidemiology, pathogenesis, clinical manifestations, course, and diagnosis. Retrieved 1/14/2024, from https://www.uptodate.com/contents/dissociative-amnesia-epidemiology-pathogenesis-clinical-manifestations-course-and-diagnosis?search=amnesia&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2# Lucas Alessandro, Mario Ricciardi, Hernán Chaves, Ricardo F. Allegri. Acute amnestic syndromes. Journal of the Neurological Sciences. Volume 413. 2020. https://doi.org/10.1016/j.jns.2020.116781. Angelica Staniloiu, Hans J Markowitsch. Dissociative amnesia. The Lancet Psychiatry. Volume 1, Issue 3. 2014. Pages 226-241. ISSN 2215-0366. https://doi.org/10.1016/S2215-0366(14)70279-2.

Drew Ramsey, MD @DrewRamseyMD is a board certified psychiatrist, author, and mental health advocate. His work focuses on clinical excellence, nutritional psychiatry, male mental health and creative media. He is an assistant clinical professor of psychiatry at Columbia University College of Physicians and Surgeons and founded the Brain Food Clinic, a digital mental health clinical practice. His work has been featured by The New York Times, The Wall Street Journal, Lancet Psychiatry, The Today Show, BBC, and NPR and he has given three TEDx talks. He is co-author of the Antidepressant Food Scale and created the first e-courses on Nutritional Psychiatry education for the public and clinicians. His books Eat to Beat Depression and Anxiety (Harperwave 2021), Eat Complete, 50 Shades of Kale, and The Happiness Diet explore the connections between mental health and nutrition. He is on the Advisory Board at Men's Health, the Editorial Board at Medscape Psychiatry, and the Scientific Advisory Board of the anti-stigma nonprofit Bring Change To Mind. He lives in Jackson, Wyoming with his wife and two children. In today's episode, Dr. Ramsey and I discuss how food can contribute to our mood. He emphasizes the importance of nourishing the brain with the right foods to optimize mental health and potentially prevent and treat mental health concerns. Dr. Ramsey also highlights the significance of educating ourselves about the nutrients our brains need, such as magnesium, vitamin E, and omega-3 fats, and where to find them in our diets. In addition to food, we touched on the topic of alternative treatments for mental health, particularly ketamine. Dr. Ramsey explained ketamine's history, its use in treating depression, and its potential to open up neuroplastic windows in the brain, offering new pathways for healing. This episode is a must-listen for anyone interested in the powerful connection between what we eat and how we feel. Dr. Ramsey's expertise and passion for nutritional psychiatry is truly inspiring, and his insights could be the key to unlocking a happier, healthier life for you! Dr. Ramsey's Instagram: https://www.instagram.com/drewramseymd/ Dr. Ramsey's Youtube: https://www.youtube.com/@DrewRamseyMD/featured Dr. Ramsey's Latest Book: https://drewramseymd.com/books-publications/eat-to-beat-depression-and-anxiety/ Healing the Modern Brain course: https://learn.drewramseymd.com/masterclass-order-evergreen/ For $250 off your Lumebox, preorder for their updated model launching this January 2024, using this link: https://justingredients.us/products/lumebox-red-light?_pos=1&_sid=e88ca0cba&_ss=r

If the conversation with Scott Galloway was the one with the frat boy turned banker turned entrepreneur going vulnerable, this one is the conversation with the thoughtful, grass-fed farmer-turned-physician. And it's equally as insightful. Drew Ramsey, MD is a board certified psychiatrist, author, and mental health advocate. His work focuses on clinical excellence, nutritional psychiatry, male mental health and creative media. He is an assistant clinical professor of psychiatry at Columbia University College of Physicians and Surgeons and founded the Brain Food Clinic, a digital mental health clinical practice.His work has been featured by The New York Times, The Wall Street Journal, Lancet Psychiatry, The Today Show, BBC, and NPR and he has given three TEDx talks. He is co-author of the Antidepressant Food Scale and created the first e-courses on Nutritional Psychiatry education for the public and clinicians. His books Eat to Beat Depression and Anxiety (Harperwave 2021), Eat Complete, 50 Shades of Kale, and The Happiness Diet explore the connections between mental health and nutrition. He is on the Advisory Board at Men's Health, the Editorial Board at Medscape Psychiatry, and the Scientific Advisory Board of the anti-stigma nonprofit Bring Change To Mind. He lives in Jackson, Wyoming with his wife and two children.Follow Dr. Drew on Instagram: @DrewRamseyMDHighlights: 3:30 - how do we define success? 4:23 - a moment to fan boy over Prof G6:47 - what's worked for Ronan since leaving Field Trip12:07 - the brilliance of association and intuition14:67 - the lies that Disney movies tell us19:30 - a really good diagnosis being a good thing22:46 - using psychedelics during periods of distress 27:00 - the beauty of not being a doctor28:50 - what is nutritional psychiatry38:00 - rethinking vulnerability42:26 - what's Justin Trudeau got to do with it? 44:57 - Drew's perspectives the Barbie Movie49:26 - how to be a good mental health clinician55:22 - a nod to Dr. Barry Waisglass and more integrated approaches to medicine1:00:38 - back to lentils1:02:46 - gluten, organic, coconut oil, ketosis and artificial flavours. And GMOs and UFOs.

Content warning: Discussion of traumatic experiencesSophia Davis, Senior Editor at The Lancet Psychiatry, is joined by Judith Lewis Herman, Duane Booysen, and Angela Sweeney to talk about the impact of trauma and routes to recovery. They discuss how ideas about trauma have changed over time, and about how trauma happens not just to an individual but within social contexts, and the recovery or healing from trauma does too. They also consider the importance of the context of different countries, of survivor-led research, and of social justice for trauma. You can see all of our Spotlight content relating to mental health here:https://www.thelancet.com/lancet-200/mental-health?dgcid=buzzsprout_tlv_podcast_lancet200_uhcFind out more about how The Lancet is marking its 200th anniversary with a series of important spotlights here:https://www.thelancet.com/lancet-200?dgcid=buzzsprout_tlv_podcast_lancet200_uhcContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Sophia Davis, Senior Editor of The Lancet Psychiatry, is joined by Laura Fischer, Sarah Garfinkel, and Simon Rosenbaum to talk about how physical and mental health are interlinked, from the connections between mental and physical health conditions, to the physiological and neurobiological mechanisms involved in mental health and ill health, and to mental health interventions that are integrating the body within them. You can see all of our Spotlight content relating to mental health here:https://www.thelancet.com/lancet-200/mental-health?dgcid=buzzsprout_tlv_podcast_lancet200_uhcFind out more about how The Lancet is marking its 200th anniversary with a series of important spotlights here:https://www.thelancet.com/lancet-200?dgcid=buzzsprout_tlv_podcast_lancet200_uhc

Welcome to PsychEd - the psychiatry podcast for medical learners, by medical learners. This episode covers the relationship between cannabis and psychotic disorders, as well as the potential impact of cannabis legalization in Canada, with our special guest Dr. Nitin Chopra. This episode was originated by Dr. Luke Fraccaro for his Grand Rounds.   The learning objectives for this episode are as follows:  By the end of this episode, you should be able to… Briefly summarize the effects of cannabis on mental health and cognition, with a focus on psychosis. Appreciate the evidence for cannabis use as a potential cause of persistent psychotic disorders. Discuss the possible impact that recent cannabis legislation may have had on cannabis use and psychosis in Canada.   Guest Expert Dr. Nitin Chopra is an addictions psychiatrist at the Centre for Addiction and Mental Health (CAMH) and is an Assistant Professor in the Department of Psychiatry at the University of Toronto. He has an interest in concurrent disorders and is a staff psychiatrist on the Concurrent Addictions Inpatient Treatment Service and Concurrent Outpatient Medical and Psychosocial Addiction Support Service. Through his work on the Psychiatry Addictions Capacity Building and Consultation Service (PACCS) at CAMH and the Addiction Medicine and Psychosocial Addictions ECHO program, he is evolving into a leader in capacity building and education for addictions treatment. Furthermore, Dr. Chopra also works on the Early Psychosis Unit at CAMH and has extensive clinical experience working with patients experiencing psychosis, often with comorbid cannabis and other substance use.    Grand Rounds Presenter: Dr. Luke Fraccaro (PGY3)   Produced by: Dr. Luke Fraccaro (PGY3), Dr. Alex Raben (staff psychiatrist), and Josh Benchaya (MS4)   Hosts: Dr. Luke Fraccaro (PGY3), Dr. Alex Raben (staff psychiatrist), and Josh Benchaya (MS4)   Audio Editing by: Dr. Luke Fraccaro (PGY3)   Show notes by: Dr. Luke Fraccaro (PGY3)   Conflicts of Interest: There are no known conflict of interests to report   Topics: 0:00 - Introduction 2:50 - Objectives 3:55 - Case example 7:25 - Overview of cannabis effects of mental health 10:45 - Differentiating clinically between cannabis-induced psychosis and a primary psychotic disorder 13:11 - Cannabis causing acute psychotic symptoms 14:15 - Back to the case 16:05 - Overlapping risk factors for cannabis use and psychotic disorders 18:14 - Cannabis use as a potential cause of persistent psychotic disorders (Reviewing the evidence) 30:14 - Summary of the relationship between cannabis and psychosis and how to apply it clinically 35:20 - Cannabis legalization in Canada 39:45 - Canadian studies on potential impact of cannabis legalization on psychosis 44:33 - Brief review of American studies on potential impact of cannabis legalization on psychosis. 46:35 - Summary of potential impact of legalization 47:42 - Questions and discussion 1:06:15 - Summary and Outro   Resources: Canada's Lower-Risk Cannabis Use Guideline: https://www.camh.ca/-/media/files/lrcug_professional-pdf.pdf Cannabis legalization and regulation in Canada: https://www.canada.ca/en/health-canada/programs/engaging-cannabis-legalization-regulation-canada-taking-stock-progress/document.html    References:  American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Arlington, VA: American Psychiatric Association, 2022.  Tourjman SV, Buck G, Jutras-Aswad D, Khullar A, McInerney S, Saraf G, Pinto JV, Potvin S, Poulin MJ, Frey BN, Kennedy SH, Lam RW, MacQueen G, Milev R, Parikh SV, Ravindran A, McIntyre RS, Schaffer A, Taylor VH, van Ameringen M, Yatham LN, Beaulieu S. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder. Can J Psychiatry. 2022 Jun 16:7067437221099769. doi: 10.1177/07067437221099769. Epub ahead of print. PMID: 35711159. Xue S, Husain MI, Zhao H, Ravindran AV. Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies. Can J Psychiatry. 2021 Feb;66(2):126-138. doi: 10.1177/0706743720952251. Epub 2020 Sep 10. PMID: 32909828; PMCID: PMC7918873. Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. Biol Psychiatry. 2016 Apr 1;79(7):557-67. doi: 10.1016/j.biopsych.2015.12.002. Epub 2015 Dec 8. PMID: 26858214. Wilkinson ST, Radhakrishnan R, D'Souza DC. Impact of Cannabis Use on the Development of Psychotic Disorders. Curr Addict Rep. 2014 Jun 1;1(2):115-128. doi: 10.1007/s40429-014-0018-7. PMID: 25767748; PMCID: PMC4352721. Hindley G, Beck K, Borgan F, Ginestet CE, McCutcheon R, Kleinloog D, Ganesh S, Radhakrishnan R, D'Souza DC, Howes OD. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry. 2020 Apr;7(4):344-353. doi: 10.1016/S2215-0366(20)30074-2. Epub 2020 Mar 17. PMID: 32197092; PMCID: PMC7738353. Ksir, C., Hart, C.L. Cannabis and Psychosis: a Critical Overview of the Relationship. Curr Psychiatry Rep 18, 12 (2016). Ganesh S, D'Souza DC. Cannabis and Psychosis: Recent Epidemiological Findings Continuing the "Causality Debate". Am J Psychiatry. 2022 Jan;179(1):8-10. doi: 10.1176/appi.ajp.2021.21111126. PMID: 34974754. Hasan A, von Keller R, Friemel CM, Hall W, Schneider M, Koethe D, Leweke FM, Strube W, Hoch E. Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412. doi: 10.1007/s00406-019-01068-z. Epub 2019 Sep 28. PMID: 31563981. Petrilli K, Ofori S, Hines L, Taylor G, Adams S, Freeman TP. Association of cannabis potency with mental ill health and addiction: a systematic review. Lancet Psychiatry. 2022 Sep;9(9):736-750. doi: 10.1016/S2215-0366(22)00161-4. Epub 2022 Jul 25. PMID: 35901795. Buchy L, Perkins D, Woods SW, Liu L, Addington J. Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophr Res. 2014 Jul;156(2-3):277-80. doi: 10.1016/j.schres.2014.04.021. Epub 2014 May 14. PMID: 24837058; PMCID: PMC4082820. Gillespie NA, Kendler KS. Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia. JAMA Psychiatry. 2021 May 1;78(5):467-468. doi: 10.1001/jamapsychiatry.2020.3564. PMID: 33146687. Johnson EC, Hatoum AS, Deak JD, Polimanti R, Murray RM, Edenberg HJ, Gelernter J, Di Forti M, Agrawal A. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction. 2021 Nov;116(11):3227-3234. doi: 10.1111/add.15534. Epub 2021 May 19. PMID: 33950550; PMCID: PMC8492483. Fischer, B., Lee, A., Robinson, T. et al. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada. Subst Abuse Treat Prev Policy 16, 77 (2021). https://doi.org/10.1186/s13011-021-00405-7 Myran DT, Imtiaz S, Konikoff L, Douglas L, Elton-Marshall T. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review. Drug Alcohol Rev. 2023 Feb;42(2):277-298. doi: 10.1111/dar.13546. Epub 2022 Sep 27. PMID: 36165188. Vignault C, Massé A, Gouron D, Quintin J, Asli KD, Semaan W. The Potential Impact of Recreational Cannabis Legalization on the Prevalence of Cannabis Use Disorder and Psychotic Disorders: A Retrospective Observational Study. Can J Psychiatry. 2021 Dec;66(12):1069-1076. doi: 10.1177/0706743720984684. Epub 2021 Feb 11. PMID: 33567893; PMCID: PMC8689454. Callaghan RC, Sanches M, Murray RM, Konefal S, Maloney-Hall B, Kish SJ. Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019. Can J Psychiatry. 2022 Aug;67(8):616-625. doi: 10.1177/07067437211070650. Epub 2022 Jan 12. PMID: 35019734; PMCID: PMC9301152. D'Souza DC, DiForti M, Ganesh S, George TP, Hall W, Hjorthøj C, Howes O, Keshavan M, Murray RM, Nguyen TB, Pearlson GD, Ranganathan M, Selloni A, Solowij N, Spinazzola E. Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis. World J Biol Psychiatry. 2022 Dec;23(10):719-742. doi: 10.1080/15622975.2022.2038797. Epub 2022 Mar 22. PMID: 35315315. Wang, G. S., Buttorff, C., Wilks, A., Schwam, D., Tung, G., & Pacula, R. L. (2022). Impact of cannabis legalization on healthcare utilization for psychosis and schizophrenia in Colorado. International Journal of Drug Policy, 104, 103685. Kim, H. S., & Monte, A. A. (2016). Colorado Cannabis Legalization and Its Effect on Emergency Care. Annals of emergency medicine, 68(1), 71–75. https://doi-org.proxy3.library.mcgill.ca/10.1016/j.annemergmed.2016.01.004   CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.   For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.

This is Garrison Hardie with your CrossPolitic Daily News Brief for Friday, March 17th, 2023. Happy Friday everyone! New Saint Andrews: Today’s culture shifts like sand, but New Saint Andrews College is established on Christ, the immovable rock. The college is a premier institution that forges evangelical leaders who don’t fear or hate the world. Guided by God’s word, equipped with the genius of classical liberal arts and God-honoring wisdom, with a faculty dedicated to academic rigor and to God’s kingdom, New Saint Andrews College offers an education that frees people. Logic and language, hard work and joyful courage, old books and godly professors — New Saint Andrews Colleges provides time-tested resources that can equip your student for any vocation. To find out more, visit: nsa.edu https://www.theepochtimes.com/health/american-children-are-dying-at-highest-rate-in-50-years_5124568.html?utm_source=partner&utm_campaign=BonginoReport American Children Are Dying at Highest Rate in 50 Years Mortality rates among American children and adolescents rose by almost 20 percent in just two years, with non-COVID injuries being a top reason for increased deaths. Between 2019 and 2020, all-cause mortality rates for Americans in the age group of 1 to 19 years jumped by 10.7 percent, according to data collected and published by JAMA Network from the American Medical Association. This was followed by an 8.3 percent spike between 2020 and 2021. The total mortality rate in the two years between 2019 and 2021 was 19 percent—the biggest increase in at least 50 years. “These increases, the largest in decades, followed a period of great progress in reducing pediatric mortality rates,” the editorial stated. “This reversal in the pediatric mortality trajectory was caused not by COVID-19, but by injuries,” the editorial stated. “In 2020, the COVID-19 mortality rate at ages 1 to 19 years was 0.24 deaths per 100 000, but the absolute increase in injury deaths alone was nearly 12 times higher (2.80 deaths per 100 000).” Between 2019 and 2020, injury mortality rose by 22.6 percent among those between the ages of 10 and 19, with homicides rising by 39.1 percent and drug overdose deaths jumping by 113.5 percent. Among children aged 1 to 9 years, injuries accounted for 63.7 percent of the increase in all-cause mortality in 2021. “We’ve now reached a tipping point where the number of injury-related deaths is so high that it is offsetting many of the gains we’ve made in treating other diseases,” said Elizabeth Wolf, an author of the editorial and an assistant professor in the department of pediatrics at the Virginia Commonwealth University’s School of Medicine. The editorial points out that the increase in injury deaths predates the pandemic. For instance, suicides among individuals between 10 and 19 years of age began to rise in 2007, with homicide rates starting to increase in 2013. Between 2007 and 2019, mortality rates for suicide rose by 69.5 percent. Between 2013 and 2019, homicide rates increased by 32.7 percent. The editorial blamed the increase in suicide and homicide rates on a “deepening” mental health crisis and access to firearms. Despite the fear created by the pandemic, the share of COVID-19 in deaths among children and young people (CYP) was lower when compared to other causes, according to a Jan. 30 study published in JAMA Network. The study identified 821 deaths among CYP aged 0 to 19 years between August 1, 2021, and July 31, 2022, in the United States and compared it with other causes of death in 2019 prior to the pandemic. COVID-19 was ranked eighth among all causes of death within this demographic, accounting for 2 percent of all causes of death. According to data from the National Center for Health Statistics, unintentional injuries were the leading cause of death among children in 2020, accounting for 12.5 percent of deaths below the age of 12 and 31.4 percent of deaths among adolescents aged 12-17. COVID-19 accounted for 0.3 percent of deaths in children under the age of 12 and 0.8 percent of deaths among those aged 12-17. Mental health among children and adolescents worsened during the pandemic per a paper published in The Lancet Psychiatry that analyzed emergency department visits. The analysis found a 22 percent jump in youth visits for suicide attempts when comparing the period prior to the pandemic to the pandemic period until July 2021. This surge in suicide visits happened even though there was a 32 percent reduction in pediatric emergency department visits for health-related reasons during the pandemic. In addition, there was also an 8 percent increase in visits for suicidal ideation—referring to individuals who entertain suicidal thoughts. A study on the National Poison Data System found that suspected suicide attempts through self-poisoning among children rose by 26.7 percent between 2015 and 2020. Speaking of children… https://hotair.com/david-strom/2023/03/15/fda-pushing-vaccine-boosters-for-infants-based-upon-trials-in-just-24-children-n537177 FDA pushing vaccine boosters for infants based upon trials in just 24 children The FDA has approved the use of a new bivalent COVID-19 booster for children 6 months old to 4 years old based upon trials that included almost no children. 24 participants for the 6-month-23-month cohort, and 36 for the 2 years through 4 years old cohort. 60 children in all. There are tens of millions of children in these age cohorts, and while this sort of trial is better than one where only 9 mice are given the jab, it strikes me as bizarre that the FDA is pushing this out the door and recommending that all children in America be vaccinated with a jab that has barely been tested. Particularly given that the COVID virus presents almost no threat to any children those ages. European countries have pulled back from recommending or even giving COVID vaccines to people under 50, except in cases where the patient is in a high-risk category. It beggars belief that the United States FDA is still going full steam ahead recommending vaccines that are not actually approved–they are being given under an Emergency Use Authorization, not full approval–to millions of children at little risk for serious disease. Even the FDA admits that there are side effects, because of course there are. There are with everything. Side effects can be justified if the benefits outweigh the downsides, but there really is no evidence that the benefits are there. Alps Precious Metals Group The Word of God in Genesis 2:10-12b teaches this: “…And a river went out of Eden to water the garden; and from thence it was parted, and became into four heads. The name of the first is Pison: that is it which compasseth the whole land of Havilah, where there is gold; And the gold of that land is good…” Gold maintains God’s stamp of approval if used with the wisdom He gives us by His Grace. Since the creation of the Federal Reserve and all of the other Central Planning Banks around the world, tumultuous modern financial markets have been the natural consequence. In the midst of these tempests, such as the one that is upon us now, Gold has maintained an impeccable record of preserving the labor and wealth of individuals, families and institutions. Alps Precious Metals is a U.S.-based company formed for the purpose of re-establishing the essential role of Physical Precious Metals within investment portfolios. Whether as a compliment or replacement for bank/brokerage accounts and/or Retirement accounts, Physical Precious Metals allow the investor to own *the* bedrock asset that has weathered all financial storms. Call James Hunter of Alps at 251-377-2197, and visit our website at www.alpspmg.com to begin the discussion of the trading and Vaulting of Physical Precious Metals. https://townhall.com/tipsheet/spencerbrown/2023/03/16/biden-administration-pursuing-a-taxpayer-funded-bailout-for-moderna-n2620646 The Biden Administration Is Trying to Bail Out Moderna While Americans' eyes and justified outrage are aimed at the Biden administration's "not a bailout" bailout of failed banks, there's an even larger bailout — and potentially a new scandal for Biden — his administration is pursuing. Specifically, the Biden Department of Justice has inserted the federal government — and with it hardworking American taxpayers — into a patent infringement dispute alleging that Moderna stole intellectual property from smaller biotech companies and used it to create and produce its COVID-19 mRNA vaccine that's since been administered more than 250 million times in the U.S. and sent the company's revenue soaring. According to the two small biotech companies alleging patent infringement — called Arbutus and Genevant — Moderna stole their vaccine delivery method that uses lipid nanoparticles (LNPs) to protect vaccine-introduced mRNA in the bloodstream and help ensure it reaches the intended target to become effective. Moderna's response to Arbutus and Genevant has not focused on the companies' claims, but sought to have the case dismissed entirely. Moderna says that, under a World War I-era law found in Section 1498 of U.S. Code, its vaccine development and production is shielded from patent claims because it was under contract to provide the vaccine to the federal government. Moderna maintains its COVID vaccine did not infringe on intellectual property, but said that "dispute is for later." Rather than allowing the case to play out on its own, the Biden administration — via Delaware U.S. Attorney David Weiss — filed a statement of interest in the dispute last month "to relieve Moderna of any liability for patent infringement resulting in performance of the ’-0100 Contract and to transfer to the United States any liability for the manufacture or use of the inventions claimed in the Patents-in-Suit resulting from the authorized and consented acts." The "-0100 Contract" mentioned by the U.S. attorney in its statement of interest is an $8.2 billion contract between Moderna and the Department of Defense coded as "pharmaceutical preparation manufacturing." So, the Biden administration appears to be stepping in and seeking to put hardworking American taxpayers on the hook for what could be potentially billions of dollars worth of liability claims caused by Moderna's alleged theft of intellectual property to make its COVID vaccine. Why would the Biden administration, after the federal government has already poured billions of dollars into Moderna for its COVID vaccine, now seek to bail them out for, potentially, billions more? And why did the Biden DOJ wait until February of 2023 to file a statement of interest when the case against Moderna has been in motion since early 2022? And that's where another twist complicates the Biden DOJ's intervention and raises more questions about how the decision to intervene was made. The U.S. attorney filed the statement of interest on behalf of the Biden DOJ on February 14 and, one day later on February 15, Moderna announced its "commitment to patient access in the United States." The company's announcement states that "Moderna remains committed to ensuring that people in the United States will have access to our COVID-19 vaccines regardless of ability to pay" and Americans who are uninsured or underinsured will still be able to get Moderna's COVID vaccines at pharmacies and doctors' offices at "no cost" to them. In 2019, the company's revenue was $60 million. It increased to $803 million in 2020, then surged to more than $18 billion in 2021. It seems as though the federal government has done enough to help Moderna by now, and yet the U.S. government intervened on Moderna's behalf in the patent infringement case to say American taxpayers should assume liability for claims stemming from the company's alleged intellectual property theft. So far, the judge hearing claims against Moderna has not sided with the company's — or the Biden DOJ's — claims that the federal government (again, read: taxpayers) should be held liable instead, and has ruled against motions to dismiss the case outright. Next week, Moderna's CEO Stéphane Bancel will testify before the Senate Health, Education, Labor and Pensions (HELP) Committee. That hearing, led by HELP Chairman Bernie Sanders (I-VT), is titled "Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?" And finally… https://www.washingtonexaminer.com/restoring-america/community-family/california-pushes-360k-person-reparations-despite-major-deficit California pushes for $360,000 per person in reparations despite major deficit The state-endorsed California Reparations Task Force is pushing to give every black resident $360,000 in reparations despite a major budget deficit. In 2020, the United States Census Bureau recorded approximately 2.251 million black people residing in California, of whom 1.8 million had at least one ancestor who was a slave, Fox News reported , making the total reparations cost around $640 billion. It is unknown where the state will come up with the funds, however, as Gov. Gavin Newsom (D-CA) reported that California is facing a budget deficit of $22.5 billion for this coming fiscal year. Chas Alamo, the state's Legislative Analyst's Office's principal fiscal and policy analyst, appeared at the Reparation Task Force's second in-person meeting, in which he proposed further steps that could be taken to fulfill the reparations plan. He proposed several different paths the task force could take to make reparations state law, including the creation of a new agency that would oversee the dispensation of reparations. "The creation of a new agency would be initiated through the governor's executive branch and reorganization process, but other options exist," Alamo said, California Black Media reported. "Regardless of the path, to initiate a new agency or enact any other recommendation that makes changes to state law, fundamentally both houses from the state legislature would have to approve the action and the governor will have to sign it." The task force is due to submit a final report and its accompanying recommendations by July 1. The state legislature, which created the commission amid the fallout from George Floyd's death in 2020, will then vote on the proposal, at which point it will be sent to Newsom to sign. So far, neither the panel nor any government agency has suggested how the reparations will be paid for. Meanwhile, a separate, city-appointed reparations task force in San Francisco recommended giving $5 million in reparations to every black resident, which would total nearly $225 billion.

This is Garrison Hardie with your CrossPolitic Daily News Brief for Friday, March 17th, 2023. Happy Friday everyone! New Saint Andrews: Today’s culture shifts like sand, but New Saint Andrews College is established on Christ, the immovable rock. The college is a premier institution that forges evangelical leaders who don’t fear or hate the world. Guided by God’s word, equipped with the genius of classical liberal arts and God-honoring wisdom, with a faculty dedicated to academic rigor and to God’s kingdom, New Saint Andrews College offers an education that frees people. Logic and language, hard work and joyful courage, old books and godly professors — New Saint Andrews Colleges provides time-tested resources that can equip your student for any vocation. To find out more, visit: nsa.edu https://www.theepochtimes.com/health/american-children-are-dying-at-highest-rate-in-50-years_5124568.html?utm_source=partner&utm_campaign=BonginoReport American Children Are Dying at Highest Rate in 50 Years Mortality rates among American children and adolescents rose by almost 20 percent in just two years, with non-COVID injuries being a top reason for increased deaths. Between 2019 and 2020, all-cause mortality rates for Americans in the age group of 1 to 19 years jumped by 10.7 percent, according to data collected and published by JAMA Network from the American Medical Association. This was followed by an 8.3 percent spike between 2020 and 2021. The total mortality rate in the two years between 2019 and 2021 was 19 percent—the biggest increase in at least 50 years. “These increases, the largest in decades, followed a period of great progress in reducing pediatric mortality rates,” the editorial stated. “This reversal in the pediatric mortality trajectory was caused not by COVID-19, but by injuries,” the editorial stated. “In 2020, the COVID-19 mortality rate at ages 1 to 19 years was 0.24 deaths per 100 000, but the absolute increase in injury deaths alone was nearly 12 times higher (2.80 deaths per 100 000).” Between 2019 and 2020, injury mortality rose by 22.6 percent among those between the ages of 10 and 19, with homicides rising by 39.1 percent and drug overdose deaths jumping by 113.5 percent. Among children aged 1 to 9 years, injuries accounted for 63.7 percent of the increase in all-cause mortality in 2021. “We’ve now reached a tipping point where the number of injury-related deaths is so high that it is offsetting many of the gains we’ve made in treating other diseases,” said Elizabeth Wolf, an author of the editorial and an assistant professor in the department of pediatrics at the Virginia Commonwealth University’s School of Medicine. The editorial points out that the increase in injury deaths predates the pandemic. For instance, suicides among individuals between 10 and 19 years of age began to rise in 2007, with homicide rates starting to increase in 2013. Between 2007 and 2019, mortality rates for suicide rose by 69.5 percent. Between 2013 and 2019, homicide rates increased by 32.7 percent. The editorial blamed the increase in suicide and homicide rates on a “deepening” mental health crisis and access to firearms. Despite the fear created by the pandemic, the share of COVID-19 in deaths among children and young people (CYP) was lower when compared to other causes, according to a Jan. 30 study published in JAMA Network. The study identified 821 deaths among CYP aged 0 to 19 years between August 1, 2021, and July 31, 2022, in the United States and compared it with other causes of death in 2019 prior to the pandemic. COVID-19 was ranked eighth among all causes of death within this demographic, accounting for 2 percent of all causes of death. According to data from the National Center for Health Statistics, unintentional injuries were the leading cause of death among children in 2020, accounting for 12.5 percent of deaths below the age of 12 and 31.4 percent of deaths among adolescents aged 12-17. COVID-19 accounted for 0.3 percent of deaths in children under the age of 12 and 0.8 percent of deaths among those aged 12-17. Mental health among children and adolescents worsened during the pandemic per a paper published in The Lancet Psychiatry that analyzed emergency department visits. The analysis found a 22 percent jump in youth visits for suicide attempts when comparing the period prior to the pandemic to the pandemic period until July 2021. This surge in suicide visits happened even though there was a 32 percent reduction in pediatric emergency department visits for health-related reasons during the pandemic. In addition, there was also an 8 percent increase in visits for suicidal ideation—referring to individuals who entertain suicidal thoughts. A study on the National Poison Data System found that suspected suicide attempts through self-poisoning among children rose by 26.7 percent between 2015 and 2020. Speaking of children… https://hotair.com/david-strom/2023/03/15/fda-pushing-vaccine-boosters-for-infants-based-upon-trials-in-just-24-children-n537177 FDA pushing vaccine boosters for infants based upon trials in just 24 children The FDA has approved the use of a new bivalent COVID-19 booster for children 6 months old to 4 years old based upon trials that included almost no children. 24 participants for the 6-month-23-month cohort, and 36 for the 2 years through 4 years old cohort. 60 children in all. There are tens of millions of children in these age cohorts, and while this sort of trial is better than one where only 9 mice are given the jab, it strikes me as bizarre that the FDA is pushing this out the door and recommending that all children in America be vaccinated with a jab that has barely been tested. Particularly given that the COVID virus presents almost no threat to any children those ages. European countries have pulled back from recommending or even giving COVID vaccines to people under 50, except in cases where the patient is in a high-risk category. It beggars belief that the United States FDA is still going full steam ahead recommending vaccines that are not actually approved–they are being given under an Emergency Use Authorization, not full approval–to millions of children at little risk for serious disease. Even the FDA admits that there are side effects, because of course there are. There are with everything. Side effects can be justified if the benefits outweigh the downsides, but there really is no evidence that the benefits are there. Alps Precious Metals Group The Word of God in Genesis 2:10-12b teaches this: “…And a river went out of Eden to water the garden; and from thence it was parted, and became into four heads. The name of the first is Pison: that is it which compasseth the whole land of Havilah, where there is gold; And the gold of that land is good…” Gold maintains God’s stamp of approval if used with the wisdom He gives us by His Grace. Since the creation of the Federal Reserve and all of the other Central Planning Banks around the world, tumultuous modern financial markets have been the natural consequence. In the midst of these tempests, such as the one that is upon us now, Gold has maintained an impeccable record of preserving the labor and wealth of individuals, families and institutions. Alps Precious Metals is a U.S.-based company formed for the purpose of re-establishing the essential role of Physical Precious Metals within investment portfolios. Whether as a compliment or replacement for bank/brokerage accounts and/or Retirement accounts, Physical Precious Metals allow the investor to own *the* bedrock asset that has weathered all financial storms. Call James Hunter of Alps at 251-377-2197, and visit our website at www.alpspmg.com to begin the discussion of the trading and Vaulting of Physical Precious Metals. https://townhall.com/tipsheet/spencerbrown/2023/03/16/biden-administration-pursuing-a-taxpayer-funded-bailout-for-moderna-n2620646 The Biden Administration Is Trying to Bail Out Moderna While Americans' eyes and justified outrage are aimed at the Biden administration's "not a bailout" bailout of failed banks, there's an even larger bailout — and potentially a new scandal for Biden — his administration is pursuing. Specifically, the Biden Department of Justice has inserted the federal government — and with it hardworking American taxpayers — into a patent infringement dispute alleging that Moderna stole intellectual property from smaller biotech companies and used it to create and produce its COVID-19 mRNA vaccine that's since been administered more than 250 million times in the U.S. and sent the company's revenue soaring. According to the two small biotech companies alleging patent infringement — called Arbutus and Genevant — Moderna stole their vaccine delivery method that uses lipid nanoparticles (LNPs) to protect vaccine-introduced mRNA in the bloodstream and help ensure it reaches the intended target to become effective. Moderna's response to Arbutus and Genevant has not focused on the companies' claims, but sought to have the case dismissed entirely. Moderna says that, under a World War I-era law found in Section 1498 of U.S. Code, its vaccine development and production is shielded from patent claims because it was under contract to provide the vaccine to the federal government. Moderna maintains its COVID vaccine did not infringe on intellectual property, but said that "dispute is for later." Rather than allowing the case to play out on its own, the Biden administration — via Delaware U.S. Attorney David Weiss — filed a statement of interest in the dispute last month "to relieve Moderna of any liability for patent infringement resulting in performance of the ’-0100 Contract and to transfer to the United States any liability for the manufacture or use of the inventions claimed in the Patents-in-Suit resulting from the authorized and consented acts." The "-0100 Contract" mentioned by the U.S. attorney in its statement of interest is an $8.2 billion contract between Moderna and the Department of Defense coded as "pharmaceutical preparation manufacturing." So, the Biden administration appears to be stepping in and seeking to put hardworking American taxpayers on the hook for what could be potentially billions of dollars worth of liability claims caused by Moderna's alleged theft of intellectual property to make its COVID vaccine. Why would the Biden administration, after the federal government has already poured billions of dollars into Moderna for its COVID vaccine, now seek to bail them out for, potentially, billions more? And why did the Biden DOJ wait until February of 2023 to file a statement of interest when the case against Moderna has been in motion since early 2022? And that's where another twist complicates the Biden DOJ's intervention and raises more questions about how the decision to intervene was made. The U.S. attorney filed the statement of interest on behalf of the Biden DOJ on February 14 and, one day later on February 15, Moderna announced its "commitment to patient access in the United States." The company's announcement states that "Moderna remains committed to ensuring that people in the United States will have access to our COVID-19 vaccines regardless of ability to pay" and Americans who are uninsured or underinsured will still be able to get Moderna's COVID vaccines at pharmacies and doctors' offices at "no cost" to them. In 2019, the company's revenue was $60 million. It increased to $803 million in 2020, then surged to more than $18 billion in 2021. It seems as though the federal government has done enough to help Moderna by now, and yet the U.S. government intervened on Moderna's behalf in the patent infringement case to say American taxpayers should assume liability for claims stemming from the company's alleged intellectual property theft. So far, the judge hearing claims against Moderna has not sided with the company's — or the Biden DOJ's — claims that the federal government (again, read: taxpayers) should be held liable instead, and has ruled against motions to dismiss the case outright. Next week, Moderna's CEO Stéphane Bancel will testify before the Senate Health, Education, Labor and Pensions (HELP) Committee. That hearing, led by HELP Chairman Bernie Sanders (I-VT), is titled "Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?" And finally… https://www.washingtonexaminer.com/restoring-america/community-family/california-pushes-360k-person-reparations-despite-major-deficit California pushes for $360,000 per person in reparations despite major deficit The state-endorsed California Reparations Task Force is pushing to give every black resident $360,000 in reparations despite a major budget deficit. In 2020, the United States Census Bureau recorded approximately 2.251 million black people residing in California, of whom 1.8 million had at least one ancestor who was a slave, Fox News reported , making the total reparations cost around $640 billion. It is unknown where the state will come up with the funds, however, as Gov. Gavin Newsom (D-CA) reported that California is facing a budget deficit of $22.5 billion for this coming fiscal year. Chas Alamo, the state's Legislative Analyst's Office's principal fiscal and policy analyst, appeared at the Reparation Task Force's second in-person meeting, in which he proposed further steps that could be taken to fulfill the reparations plan. He proposed several different paths the task force could take to make reparations state law, including the creation of a new agency that would oversee the dispensation of reparations. "The creation of a new agency would be initiated through the governor's executive branch and reorganization process, but other options exist," Alamo said, California Black Media reported. "Regardless of the path, to initiate a new agency or enact any other recommendation that makes changes to state law, fundamentally both houses from the state legislature would have to approve the action and the governor will have to sign it." The task force is due to submit a final report and its accompanying recommendations by July 1. The state legislature, which created the commission amid the fallout from George Floyd's death in 2020, will then vote on the proposal, at which point it will be sent to Newsom to sign. So far, neither the panel nor any government agency has suggested how the reparations will be paid for. Meanwhile, a separate, city-appointed reparations task force in San Francisco recommended giving $5 million in reparations to every black resident, which would total nearly $225 billion.

This episode is the next installment of ‘Coping skills for adults' and I want to focus on the movement style. Movement and exercise is a strange one. Before doing it, you really don't want to, it takes a lot of momentum but once you've completed a workout don't you just feel amazing with all those feel-good hormones running through your body? This isn't just a feeling, it's been scientifically proven! Movement helps your physical functioning, studies also show it improves your cognitive function but most interestingly exercise improves your mental health. The topics I cover in this episode are:How can exercise help?What types of exercise are best?Working out what works for you with exerciseDifferent exercises to try out; boxing, swimming, hula hooping, golfing etcKeeping exercise sustainableThe ways I enjoy exerciseAnd remember, do not forget about yourself, take a few minutes for you and have a little fun!—Resources mentioned in the podcastChekroud, S.R., Gueorguieva, R., Zheutlin, A.B, Paulus, M., Harlan M Krumholz, H.M., Krystal, J.H., Adam M Chekroud, A.M. Exercise is known to be associated with reduced risk of all-cause mortality. (2018, August 8). Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: A cross-sectional study. The Lancet Psychiatry. Retrieved December 19, 2022, from https://www.sciencedirect.com/science/article/pii/S221503661830227XFalck RS; Davis JC; Best JR; Crockett RA;Liu-Ambrose T; (n.d.). Impact of exercise training on physical and cognitive function among older adults: A systematic review and meta-analysis. Neurobiology of aging. Retrieved December 19, 2022, from https://pubmed.ncbi.nlm.nih.gov/31051329/NY Times Article - What's the best type of exercisehttps://www.nytimes.com/2011/04/17/magazine/mag-17exercise-t.htmlKettlebell strength training and bodysurfer - Wendy Snyderhttps://www.janinehalloran.com/podcast/calm-and-connected-episode-108Barre 3 and kitchen dancing - Marcelle Waldman https://www.janinehalloran.com/podcast/calm-and-connected-episode-101About The Host - Janine HalloranJanine Halloran is a Licensed Mental Health Counselor, an author, a speaker, an entrepreneur and a mom. As a Licensed Mental Health Counselor, Janine has been working primarily with children and adolescents for over 15 years. She loves to create products and resources, so she started two businesses to support families and professionals who work with children and teens. ‘Coping Skills for Kids' provides products and resources to help kids learn to cope with their feelings in safe and healthy ways. It's the home of the popular Coping Cue Cards, decks of cards designed to help kids learn and use coping skills at home or at school. Janine's second business ‘Encourage Play' is dedicated to helping kids learn and practice social skills in the most natural way - through play! Encourage Play has free printables, as well as digital products focused on play and social skills.Coping Skills for Kids - https://copingskillsforkids.comEncourage Play - https://www.encourageplay.comInterested in reading my books? The Coping Skills for Kids Workbook - https://store.copingskillsforkids.com/collections/coping-skills-for-kids-workbook/products/coping-skills-for-kids-workbook-digital-versionSocial Skills for Kids - https://store.copingskillsforkids.com/collections/encourage-play/products/social-skills-for-kids-workbookConnect with Janine on Social MediaInstagram: @copingskillsforkidsFacebook: facebook.com/copingskillsforkids and facebook.com/encourageplayYoutube: https://www.youtube.com/c/JanineHalloranEncouragePlay

Amidst the battle of the mental health crisis, major depressive disorder stands out as an all-too-common reality for many children and adolescents, but the forces of science and medicine can stand against this foe. Dr. Christopher Drescher, a clinical child psychologist, joins pediatric resident Dr. Daniel Allen and medical student Vuk Lacmanovic to remove the cape from this increasingly common condition and discuss its symptoms, diagnosis, and treatment. Specifically, they will: Define major depressive disorder (MDD) and recognize the common symptoms in both children and adolescents. Formulate a differential diagnosis for patients presenting with depressive symptoms. Recognize validated screening tools for depression in both children and adolescents. Review cognitive behavioral therapy and pharmacotherapy as treatment options. Review appropriate referral to a mental health specialist. Free CME Credit (requires sign-in): https://mcg.cloud-cme.com/course/courseoverview?P=0&EID=12493  References: Bhatia SK, Bhatia SC. Childhood and adolescent depression. Am Fam Physician. 2007 Jan 1;75(1):73-80. PMID: 17225707. Brent DA, Maalouf F. Depressive Disorders (in Childhood and Adolescence). In: Ebert MH, Leckman JF, Petrakis IL. eds. Current Diagnosis & Treatment: Psychiatry, 3e. McGraw-Hill; Accessed November 17, 2020. https://accessmedicine.mhmedical.com/content.aspx?bookid=2509§ionid=200807606 Clark MS, Jansen KL, Cloy JA. Treatment of childhood and adolescent depression. Am Fam Physician. 2012 Sep 1;86(5):442-8. PMID: 22963063. Fendrich M, Weissman MM, Warner V. Screening for depressive disorder in children and adolescents: validating the Center for Epidemiologic Studies Depression Scale for Children. Am J Epidemiol. 1990 Mar;131(3):538-51. doi: 10.1093/oxfordjournals.aje.a115529. PMID: 2301363. (PDF of CES-DC here) Forman-Hoffman V, McClure E, McKeeman J, Wood CT, Middleton JC, Skinner AC, Perrin EM, Viswanathan M. Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Mar 1;164(5):342-9. doi: 10.7326/M15-2259. Epub 2016 Feb 9. PMID: 26857836. Hathaway EE, Walkup JT, Strawn JR. Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough? Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):31-39. doi: 10.1016/j.cppeds.2017.12.002. Epub 2018 Jan 12. PMID: 29337001; PMCID: PMC5828899. March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. doi: 10.1001/archpsyc.64.10.1132. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101. PMID: 17909125. Meister R, Abbas M, Antel J, Peters T, Pan Y, Bingel U, Nestoriuc Y, Hebebrand J. Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis. Eur Child Adolesc Psychiatry. 2020 Mar;29(3):253-273. doi: 10.1007/s00787-018-1244-7. Epub 2018 Dec 8. PMID: 30535589; PMCID: PMC7056684. Rachel A. Zuckerbrot, Amy Cheung, Peter S. Jensen, Ruth E.K. Stein, Danielle Laraque and GLAD-PC STEERING GROUP. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics March 2018, 141 (3) e20174081; DOI: https://doi.org/10.1542/peds.2017-4081 Scott K, Lewis CC, Marti CN. Trajectories of Symptom Change in the Treatment for Adolescents With Depression Study. J Am Acad Child Adolesc Psychiatry. 2019 Mar;58(3):319-328. doi: 10.1016/j.jaac.2018.07.908. Epub 2019 Jan 8. PMID: 30768414; PMCID: PMC6557284. Sharma T, Guski LS, Freund N, Gøtzsche PC. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ. 2016 Jan 27;352:i65. doi: 10.1136/bmj.i65. PMID: 26819231; PMCID: PMC4729837. Siu AL; US Preventive Services Task Force. Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics. 2016 Mar;137(3):e20154467. doi: 10.1542/peds.2015-4467. Epub 2016 Feb 8. PMID: 26908686. Weersing VR, Brent DA, Rozenman MS, Gonzalez A, Jeffreys M, Dickerson JF, Lynch FL, Porta G, Iyengar S. Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Jun 1;74(6):571-578. doi: 10.1001/jamapsychiatry.2017.0429. PMID: 28423145; PMCID: PMC5539834. Weersing VR, Shamseddeen W, Garber J, Hollon SD, Clarke GN, Beardslee WR, Gladstone TR, Lynch FL, Porta G, Iyengar S, Brent DA. Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):219-26. doi: 10.1016/j.jaac.2015.12.015. Epub 2016 Jan 18. PMID: 26903255; PMCID: PMC4783159. Xu Y, Bai SJ, Lan XH, Qin B, Huang T, Xie P. Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability. Braz J Med Biol Res. 2016 May 24;49(6):e4806. doi: 10.1590/1414-431X20164806. PMID: 27240293; PMCID: PMC4897997. Zhou X, Cipriani A, Zhang Y, Cuijpers P, Hetrick SE, Weisz JR, Pu J, Giovane CD, Furukawa TA, Barth J, Coghill D, Leucht S, Yang L, Ravindran AV, Xie P. Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis. BMJ Open. 2017 Aug 11;7(8):e016608. doi: 10.1136/bmjopen-2017-016608. PMID: 28801423; PMCID: PMC5629731. Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jul;7(7):581-601. doi: 10.1016/S2215-0366(20)30137-1. PMID: 32563306; PMCID: PMC7303954.

Video: Peterson Tells Millennials Why They CAN'T Change The World.. (8:03) “WATCH OUT! It started…” – Peter Schiff's Last WARNING (10:07) So THIS is how they plan to screw these companies, from inside out | Redacted with Clayton Morris (2:48) Higher vitamin C levels associated with lower mortality risk during 16-year period Chinese Academy of Medical Sciences, November 25, 2022 A study reported in the Journal of Epidemiology and Community Health has uncovered an association between higher plasma vitamin C levels and a lower risk of mortality during more than 16 years of follow-up. The study included 473 men and 475 women between the ages of 53 and 84 who were enrolled in the General Population Nutrition Intervention Trial (NIT) cohort in Linxian, China. Plasma samples collected from 1999 to 2000 were analyzed for vitamin C levels. During the 16.4-year follow-up period, among subjects whose plasma vitamin C concentrations were among the top 25%, the adjusted risk of dying from any cause during follow-up was 25% lower than the risk experienced by subjects whose vitamin C levels were among the lowest quarter. Those whose plasma vitamin C levels were among the highest 25% had an adjusted risk of dying from cancer or stroke that was 28% lower and a risk of dying from heart disease that was 35% lower than subjects whose levels were lowest. When subjects with low vitamin C levels (defined as 28 micromoles per liter or below) and normal levels (greater than 28 micromoles per liter) were compared, a normal level was associated with a 23% lower risk of premature mortality and a 38% lower risk of dying from heart disease, in comparison with low levels. As a possible reason for their findings, Shao-Ming Wang and colleagues note that oxidative stress is lowered by vitamin C. Oxidative stress can promote endothelial dysfunction that underlies heart disease by increasing inflammation and lipid peroxidation and decreasing nitric oxide availability. Oxidative stress also causes DNA damage associated with cancer.”This study is the first to find the general benefits for higher plasma vitamin C concentrations on total and cause-specific mortalities, including cancer and heart diseases, in a long-term prospective cohort from China,” the authors announce. “In this long-term prospective Chinese cohort study, higher plasma vitamin C concentration was associated with lower total mortality, heart disease mortality, and cancer mortality. Our results corroborate the importance of adequate vitamin C to human health.” (next) Cauliflower Prevent Various Cancers: Thanks to Sulforaphane Compounds Rugters University, November 19, 2022 Cauliflower contains glucosinolates and thiocyanates — both sulfur-containing phytonutrients that cleanse the body of damaging free radicals. It also contains a substance called sulforaphane (SFN), a compound known to inhibit the occurrence of some cancers in rats caused by carcinogens, primarily colon cancer. In the Rutger's research, it was found once again that diet does matter in cancer prevention: “Our research has substantiated the connection between diet and cancer prevention, and it is now clear that the expression of cancer-related genes can be influenced by chemopreventive compounds in the things we eat,” said Kong, a professor of pharmaceutics in the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey. In this particular study, mice fed a diet high in sulforaphane, the substance naturally occurring in cauliflower and broccoli, enjoyed fewer cancerous tumors, polyps, and smaller tumors in their colons. After three weeks, the mice fed sulforaphane had a 25% decline in tumors and those given double the dose had a 47% decrease in cancerous tumors. The results are obvious, “Our results showed that SFN produced its cancer preventive effects in the mice by inducing apoptosis (programmed cell death) and inhibiting proliferation of the tumors; however, it was not clear what mechanism SFN employs to accomplish this,” Kong said. Kong's team found that SFN suppressed certain enzymes or kinases that are highly expressed both in the mice and in patients with colon cancer. The researchers concluded that this enzymatic suppression activity is the likely basis for the chemopreventive effects of SFN. Along with cauliflower's high levels of SFN, it is also a powerful antioxidant with high levels of vitamin C and vitamin A, also known as cancer inhibitors. Researchers also believe that if you consume cauliflower and turmeric spice together, you can prevent or eradicate prostate cancer totally. The scientists, once again from Rutger's, tested turmeric and it's active compound known as curcumin along with phenethyl isothiocyanate (PEITC), a naturally occurring substance in certain vegetables such as watercress, cabbage, winter cress, broccoli, Brussels sprouts, kale, cauliflower, kohlrabi and turnips. They found cancer-preventative qualities in the duo. (next) Increasing protein intake by 25 g a day could help women reduce hip fracture risk by up to 14% University of Leeds (UK), November 28, 2022 Increasing intake of protein and drinking regular cups of tea or coffee is one way women could reduce their risk of suffering a hip fracture, according to new research. Food scientists at the University of Leeds in the UK have found that for women, a 25 g a day increase in protein was associated with, on average, a 14% reduction in their risk of hip fracture. In a surprise twist, they also discovered that every additional cup of tea or coffee they drank was linked with a 4% reduction in risk. Writing in the journal Clinical Nutrition, the researchers noted that the protective benefits were greater for women who were underweight, with a 25 g/day increase in protein reducing their risk by 45%. The investigation—”Foods, nutrients and hip fracture risk: A prospective study of middle-aged women”—is based on a large observational analysis of more than 26,000 women. As an observational study, the researchers were able to identify associations between factors in diet and health. They could not single out direct cause and effect. “Diet is a factor that people can modify to protect themselves by maintaining healthy bones and muscles. This study is one of the first to investigate relationships between food and nutrient intakes and risk of hip fracture, with hip fractures accurately identified through hospital records.” The recommended protein intake in the UK is 0.8 g per kilogram of bodyweight per day, a limit some nutritional experts believe is too low. As the study revealed, people who had a higher protein consumption had a reduction in the risk of hip fracture. However, intakes of protein which are very high—where intake is greater than 2 to 3 g of protein/kg body weight/day—can have negative health effects. The study was not able to explore these very high protein intake levels. Professor Janet Cade, who leads the Nutritional Epidemiology Group at Leeds and supervised the research, said, “In the UK most people eat an adequate amount of protein, however, certain groups, such as vegetarians or vegans need to check that their protein intakes are high enough for good health.”Tea and coffee both contain biologically active compounds called polyphenols and phytoestrogens which may help to maintain bone health. Professor Cade added, “This is an interesting finding given that tea and coffee are the UK's favorite drinks. We still need to know more about how these drinks could affect bone health but it might be through promoting the amount of calcium present in our bones.” (next) Mindfulness meditation trumps placebo in pain reduction Wake Forest Medical Center – November 11, 2022 Scientists at Wake Forest Baptist Medical Center have found new evidence that mindfulness meditation reduces pain more effectively than placebo. This is significant because placebo-controlled trials are the recognized standard for demonstrating the efficacy of clinical and pharmacological treatments. The research, published in the Journal of Neuroscience, showed that study participants who practiced mindfulness meditation reported greater pain relief than placebo. Significantly, brain scans showed that mindfulness meditation produced very different patterns of activity than those produced by placebo to reduce pain. “We were completely surprised by the findings,” said Fadel Zeidan, Ph.D., assistant professor of neurobiology and anatomy at Wake Forest Baptist and lead investigator of the study. “While we thought that there would be some overlap in brain regions between meditation and placebo, the findings from this study provide novel and objective evidence that mindfulness meditation reduces pain in a unique fashion.”Pain was induced by using a thermal probe to heat a small area of the participants' skin to 49 degrees Centigrade (120.2 degrees Fahrenheit), a level of heat most people find very painful. Study participants then rated pain intensity (physical sensation) and pain unpleasantness (emotional response). The participants' brains were scanned with arterial spin labeling magnetic resonance imaging (ASL MRI) before and after their respective four-day group interventions. The mindfulness meditation group reported that pain intensity was reduced by 27 percent and by 44 percent for the emotional aspect of pain. In contrast, the placebo cream reduced the sensation of pain by 11 percent and emotional aspect of pain by 13 percent. “The MRI scans showed for the first time that mindfulness meditation produced patterns of brain activity that are different than those produced by the placebo cream,” Zeidan said. Mindfulness meditation reduced pain by activating brain regions (orbitofrontal and anterior cingulate cortex) associated with the self-control of pain while the placebo cream lowered pain by reducing brain activity in pain-processing areas (secondary somatosensory cortex). Another brain region, the thalamus, was deactivated during mindfulness meditation, but was activated during all other conditions. This brain region serves as a gateway that determines if sensory information is allowed to reach higher brain centers. By deactivating this area, mindfulness meditation may have caused signals about pain to simply fade away, Zeidan said. Mindfulness meditation also was significantly better at reducing pain intensity and pain unpleasantness than the placebo meditation. The placebo-meditation group had relatively small decreases in pain intensity (9 percent) and pain unpleasantness (24 percent). The study findings suggest that placebo meditation may have reduced pain through a relaxation effect that was associated with slower breathing. “This study is the first to show that mindfulness meditation is mechanistically distinct and produces pain relief above and beyond the analgesic effects seen with either placebo cream or sham meditation,” Zeidan said. “Based on our findings, we believe that as little as four 20-minute daily sessions of mindfulness meditation could enhance pain treatment in a clinical setting. However, given that the present study examined healthy, pain-free volunteers, we cannot generalize our findings to chronic pain patients at this time. (next) Shaking less salt on your food at the table could reduce heart disease risk Researchers found a link between a lower frequency of dietary salt and a reduced CVD risk Tulane University, November 27, 2022 Adding additional salt to foods at a lower frequency is associated with a reduced risk of heart disease, heart failure and ischemic heart disease, according to a new study published in the Journal of the American College of Cardiology. Even among those following a DASH-style diet, behavioral interventions to lessen salt consumption could further improve heart health. “Overall, we found that people who don't shake on a little additional salt to their foods very often had a much lower risk of heart disease events, regardless of lifestyle factors and pre-existing disease,” said Lu Qi, MD, Regents Distinguished Chair at the School of Public Health and Tropical Medicine at Tulane University in New Orleans. “We also found that when patients combine a DASH diet with a low frequency of adding salt, they had the lowest heart disease risk. This is meaningful as reducing additional salt to food, not removing salt entirely, is an incredibly modifiable risk factor that we can hopefully encourage our patients to make without much sacrifice.” In the current study, the authors evaluated whether the frequency of adding salt to foods was linked with incident heart disease risk in 176,570 participants from the UK Biobank. The study also examined the association between the frequency of adding salt to foods and the DASH diet as it relates to heart disease risk. The study used a questionnaire at baseline to collect data on the frequency of adding salt to foods, not including salt used in cooking. Participants were also asked if they had made any major changes to their diet in the last 5 years, as well as complete 1-5 rounds of 24-hour dietary recalls over a three-year period. The DASH-style diet was developed to prevent hypertension by limiting consumption of red and processed meats and focusing on vegetables, fruit, whole grains, low-fat dairy, nuts, and legumes. While the DASH diet has yielded benefits in relation to reducing cardiovascular disease risk, a recent clinical trial found that combining the DASH diet with sodium reduction was more beneficial for certain cardiac biomarkers, including cardiac injury, strain, and inflammation. The researchers calculated a modified DASH score that did not consider sodium intake based on seven foods and nutrients that were emphasized or deemphasized in the DASH-style diet. Overall, study participants with a lower frequency of adding salt to foods were more likely to be women; white; have a lower body mass index; more likely to have moderate alcohol consumption; less likely to be current smokers; and more physically active. They also had a higher prevalence of high blood pressure and chronic kidney disease, but a lower prevalence of cancer. These participants were also more likely to adhere to a DASH-style diet and consumed more fruits, vegetables, nuts and legumes, whole grains, low-fat dietary but less sugar-sweetened drinks or red/processed meats than those with a higher frequency of adding salt to foods. The researchers found the association of adding salt to foods with heart disease risk was stronger in participants of lower socioeconomic status, as well as in current smokers. A higher modified DASH diet score was associated with lower risk of heart disease events. (next) Ten minutes of aerobic exercise with exposure therapy found to reduce PTSD symptoms University of New South Wales, November 25, 2022 Exposure therapy is one of the leading treatments for post-traumatic stress disorder (PTSD), but up to a half of all patients don't respond to it. But now a study led by UNSW Sydney psychologists has found that augmenting the therapy with 10 minutes of aerobic exercise has led to patients reporting greater reduction to PTSD symptom severity six months after the nine-week treatment ended. In the first known single-blind randomized control trial of its kind, researchers in Sydney recruited 130 adults with clinically diagnosed PTSD and assigned them to two groups. People in both groups received nine 90-minute exposure therapy sessions. At the end of each session, one group was put through 10 minutes of aerobic exercises, while members of the control group were given 10 minutes of passive stretching. People in the aerobic exercise group on average reported lower severity of PTSD symptoms—as measured on the CAPS-2 scale—than those who had their exposure therapy augmented by stretching exercises at the six-month follow-up. Interestingly, there were no clear differences between the two groups one week after the treatment program ended, suggesting the benefits take time to develop. The findings were reported in The Lancet Psychiatry.

Millions of people start taking antidepressants every year. But how many stop? Despite what we have heard for years, the process of withdrawing from antidepressant medications can be long, unpleasant, and even dangerous. Today's guest is one of the foremost researchers in “deprescribing” or withdrawing from antidepressants. Join us as Dr. Mark Horowitz from University College London explains the possible side effects of withdrawal, how to taper slowly and safely, and why you might want to consider going off antidepressants. To learn more -- or read the transcript -- visit the official episode page. Guest Bio Dr. Mark Horowitz, MBBS, PhD, is a Clinical Research Fellow in Psychiatry at the National Health Service (NHS) in England, an Honorary Clinical Research Fellow at University College London, and is a training psychiatrist. He has a PhD from the Institute of Psychiatry, Psychology and Neuroscience at King's College London in the neurobiology of depression and antidepressant action. He is an associate editor of the journal Therapeutic Advances in Psychopharmacology. He co-authored the recent Royal College of Psychiatry guidance on “Stopping Antidepressants,” and his work informed the recent NICE guidelines on safe tapering of psychiatric medications. He has written several papers about safe approaches to tapering psychiatric medications, including publications in The Lancet Psychiatry, JAMA Psychiatry, and Schizophrenia Bulletin. He has an interest in rational psychopharmacology and deprescribing psychiatric medication and co-founded Outro Health, the first personalized, clinician-guided service for coming off antidepressants. He has experienced the difficulty of withdrawing from psychiatric medications firsthand, which has informed much of his work. Inside Mental Health Podcast Host Gabe Howard is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To book Gabe for your next event or learn more about him, please visit gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Upgrade your Brain with Julia Rucklidge Julia J. Rucklidge, PhD, is a Professor of Psychology and a Clinical Psychologist in the School of Psychology, Speech and Hearing at the University of Canterbury, the Director of Te Puna Toiora, the Mental Health and Nutrition Research Lab, theme leader in the Child Wellbeing Institute, and co-author of The Better Brain jointly published by Penguin Random House and Harper Collins in 2021.  Originally from Toronto, Canada, she completed her PhD at the University of Calgary in clinical psychology and in 2000, she immigrated to New Zealand. Her interests in nutrition and mental illness grew out of research showing poor outcomes for individuals with significant psychiatric illness despite receiving standard conventional treatments.  For over a decade, her lab has been running clinical trials investigating the role of broad-spectrum micronutrients in the treatment of mental illness, including ADHD, mood disorders, anxiety and stress. Julia has over 140 peer reviewed publications, including in the Lancet Psychiatry, JAMA and the British Journal of Psychiatry and is currently on the Executive Committee for the International Society of Nutritional Psychiatry Research.   Grab your copy of “The Better Brain” here - https://thebetterbrainbook.com/julia-j-rucklidgeWatch Julia's TedX talk here - https://www.tedxchristchurch.com/julia-rucklidge ----Full Transcript, Quote Cards, and a Show Summary are available here:https://www.jjlaughlin.com/blog

Upgrade your Brain with Julia Rucklidge Julia J. Rucklidge, PhD, is a Professor of Psychology and a Clinical Psychologist in the School of Psychology, Speech and Hearing at the University of Canterbury, the Director of Te Puna Toiora, the Mental Health and Nutrition Research Lab, theme leader in the Child Wellbeing Institute, and co-author of The Better Brain jointly published by Penguin Random House and Harper Collins in 2021.  Originally from Toronto, Canada, she completed her PhD at the University of Calgary in clinical psychology and in 2000, she immigrated to New Zealand. Her interests in nutrition and mental illness grew out of research showing poor outcomes for individuals with significant psychiatric illness despite receiving standard conventional treatments.  For over a decade, her lab has been running clinical trials investigating the role of broad-spectrum micronutrients in the treatment of mental illness, including ADHD, mood disorders, anxiety and stress. Julia has over 140 peer reviewed publications, including in the Lancet Psychiatry, JAMA and the British Journal of Psychiatry and is currently on the Executive Committee for the International Society of Nutritional Psychiatry Research.   Grab your copy of “The Better Brain” here - https://thebetterbrainbook.com/julia-j-rucklidgeWatch Julia's TedX talk here - https://www.tedxchristchurch.com/julia-rucklidge ----Full Transcript, Quote Cards, and a Show Summary are available here:https://www.jjlaughlin.com/blog

In this episode, Dr. Ettensohn addresses common questions about therapy for NPD, discussing the current lack of competent therapists, where to find therapists who understand narcissism, and why it isn't effective to treat NPD on your own.  References:  Blagys, M.D., & Hilsenroth, M.J. (2000). Distincitve activities of short-term psychodynamic-interpersonal psychotherapy: A review of the comparative psychotherapy process literature. Clinical Psychology: Science and Practice, 7, 167-188. Johnson, S. M. (1987). Humanizing the narcissistic style. New York: W.W. Norton & Co. Shedler, J. (2010). The efficacy of psychodynamic psychotherapy. American Psychologist, 65(2), 98-109 Ulberg, R., & Hanne-Sofie, JD. (2018). Empirical support for the psychoanalytic concepts. The Lancet Psychiatry, 5(7), 543-544 Music: www.bensound.com

Dr. Ayana Jordan is a renowned expert in addiction and other mental health conditions, newly recruited to NYU to an endowed professorship for her fascinating research. For this episode of Flourishing After Addiction, I was excited to talk to her about new frontiers in her research, such as incorporating spirituality and health equity in addiction medicine. What I was not expecting was for her to share so openly and courageously about the way substance use problems have impacted her own family. It was a powerful conversation with a powerful voice in the field. It never fails to astonish me: the scope and reach of addiction into so many people's lives. Reading the stats is one thing, but to experience how it touches so many people, again and again, is truly striking.Ayana talks about her longstanding interest in integrating spirituality in addiction treatment, while simultaneously respecting people's values and beliefs, and doing so in a responsible and effective way. We discuss her work on harm reduction, racial justice, and health equity. She helps us think through how to work effectively with the social and structural determinants of health. And, we tackle the controversial question: what's the point of spirituality in the medical treatment of addiction in the first place?Ayana Jordan, MD PhD, is a renowned expert in addiction and other mental health conditions in underserved populations. She is the newly appointed Barbara Wilson Endowed Associate Professor of Psychiatry in the Department of Psychiatry at NYU, also with appointments and leadership positions in their department of Population Health, as well as NYU Langone's Institute for Excellence in Health Equity. The fundamental message of equity and inclusion has informed her research, clinical work, and leadership duties at NYU and beyond. She earned her MD PhD at Albert Einstein College of Medicine, and while training in the South Bronx, Dr. Jordan became passionate about serving racial and ethnic minoritized populations. She did her general adult psychiatry residency at Yale University, where she also served as chief resident. She has published dozens of peer-reviewed articles in numerous top-tier medical publications, serves on multiple editorial boards, and she is a thought leader who has given a wide range of keynote presentation both nationally and internationally. You can find her on her faculty page, Twitter, and Instagram.In this episode: - Information on naloxone (Narcan), including naloxone's availability in all 50 states.- Lancet Psychiatry profile of her- for more on her research, see many more of her publications linked on her NYU pageSign up for my newsletter and immediately receive my own free guide to the many pathways to recovery, as well as regular updates on new interviews, material, and other writings.

Nella puntata di oggi passeremo in rassegna alcuni degli avvenimenti che hanno fatto notizia questa settimana. Parleremo, innanzitutto, della proposta di vietare l'ingresso in Europa ai turisti russi, che ha creato non poche divisioni all'interno dell'Unione Europea. Quindi, ci sposteremo in Finlandia per commentare l'ondata di critiche che ha investito il primo ministro finlandese, Sanna Marin, per essere stata ritratta in un video, mentre balla e beve a una festa privata. A seguire, nella parte scientifica del nostro programma, analizzeremo i risultati di un recente studio, pubblicato sulla rivista Lancet Psychiatry, che descrive l'impatto neurologico e psichiatrico, a lungo termine, dell'infezione da coronavirus.    Passiamo, adesso, alla seconda parte del nostro programma, “Trending in Italy”. In primo luogo parleremo della secca del fiume Po e del ritrovamento in provincia di Mantova di una bomba inesplosa, risalente alla Seconda guerra mondiale. Quindi, ci sposteremo a Monteprato di Nimis, in Friuli-Venezia Giulia, dove ogni anno si svolge una festa, peraltro da molti contestata, dedicata al genere maschile inteso come simbolo di fertilità. - L'Europa è divisa sulla proposta di vietare l'ingresso ai turisti russi - Negativo il test anti droga della premier finladense, Sanna Marin - Conseguenze neurologiche e psichiatriche a lungo termine del coronavirus - L'Italia si prepara a portare la Slovenia in tribunale per l'aceto balsamico - La siccità del Po riporta alla luce un bomba inesplosa della Seconda guerra mondiale - Polemiche a Monteprato di Nimis durante la festa degli uomini

Nous commencerons par discuter de quelques sujets d'actualité qui ont fait les gros titres cette semaine. Tout d'abord, nous commenterons les divisions au sein de l'Union européenne concernant la proposition d'interdire l'entrée des touristes en provenance de Russie. Ensuite, nous aborderons la vague de critiques à laquelle fait face la Première ministre finlandaise, Sanna Marin, suite à la publication d'une vidéo la montrant en train de danser et de boire lors d'une fête privée. Puis, dans la partie scientifique de notre émission, nous discuterons d'une étude récente publiée dans la revue Lancet Psychiatry qui montre l'impact neurologique et psychiatrique à long terme du Covid. Et enfin, nous parlerons de la décision du gouvernement italien de lancer des poursuites contre la Slovénie au sujet du vinaigre balsamique.    Dans la deuxième partie de notre émission, « Trending in France », nous parlerons d'un phénomène préoccupant qui a entraîné la fermeture temporaire de plages en Bretagne. Et nous finirons en discutant de la polémique qui a entouré la plateforme médicale Doctolib ces derniers jours, et qui a relancé le débat sur les médecines alternatives. - Interdiction d'entrée des touristes russes : l'Europe est divisée - La Première ministre finlandaise Sanna Marin a été testée négative lors d'un test de dépistage de drogues - Les conséquences neurologiques et psychiatriques à long terme du Covid - L'Italie veut poursuivre la Slovénie en justice au sujet du vinaigre balsamique - Les algues vertes : un fléau pour les plages de Bretagne - Doctolib au coeur d'un débat sur les médecines alternatives

Comenzaremos con algunas de las noticias que acapararon titulares esta semana. Primero comentaremos las divisiones en el seno de la Unión Europea, en relación a la propuesta de prohibir la entrada de turistas rusos. A continuación, comentaremos la ola de críticas contra la primera ministra finlandesa, Sanna Marin, tras filtrarse un vídeo en el que aparecía bailando y bebiendo en una fiesta privada. Después, en la sección de ciencia del programa, discutiremos un estudio reciente publicado en la revista Lancet Psychiatry, que muestra los efectos neurológicos y psiquiátricos a largo plazo de la infección del coronavirus. Y, finalmente, discutiremos la decisión del Gobierno italiano de iniciar un procedimiento de infracción contra Eslovenia por el vinagre balsámico. En la segunda parte del programa, “Trending in Spain”, hablaremos de dos malas prácticas denunciadas por diferentes colectivos. En la primera noticia, discutiremos cómo hemos podido llegar a la crisis hídrica que este año vive España. En la segunda noticia, comentaremos el dictamen de la ONU que da la razón a una mujer vasca. Su veredicto: violencia obstétrica. Europa está dividida con respecto a si prohibir la entrada de turistas rusos La primera ministra finlandesa Sanna Marin da negativo en un test de drogas tras una fiesta Los efectos neurológicos y psiquiátricos a largo plazo de la infección de coronavirus Italia se prepara para llevar a Eslovenia ante los tribunales en relación al vinagre balsámico Restricciones de agua Violencia obstétrica

We all need to eat. Why not choose foods that are great for your brain? New research confirms what we've all suspected: your mood and thinking are strongly linked to your food intake. So let's make great choices! Listen in as psychiatrist, Dr. Jennifer Reid, MD, speaks with Dr. Drew Ramsey, MD, a leader in the field of nutritional psychiatry.   Topics we Discuss:*When it comes to anxiety and depression, how important is the way we eat?*What are the key nutrients we want to find in our food?*Why aren't supplements an insurance policy for poor diets?*How can we eat well on a tight budget?Drew Ramsey, MD @DrewRamseyMD is a psychiatrist, author, and farmer. He is an assistant clinical professor of psychiatry at Columbia University College of Physicians and Surgeons and in active telemedicine clinical practice based in New York City. His work has been featured by The New York Times, The Wall Street Journal, Lancet Psychiatry, The Today Show, BBC, and NPR and he has given three TEDx talks. He is the co-author of the Antidepressant Food Scale and his e-courses on Nutritional Psychiatry education for the public and clinicians. His books Eat to Beat Depression and Anxiety (Harperwave 2021), Eat Complete, 50 Shades of Kale, and The Happiness Diet explore the connections between mental health and nutrition. He is on the Advisory Board at Men's Health, the Editorial Board at Medscape Psychiatry, and is a member of the Well+Good Wellness Council.Drew Ramsey, MD on Instagram: @DrewRamseyMDJennifer Reid, MD on Instagram: @TheReflectiveDocLooking for more from The Reflective Doc? Subscribe today so you don't miss out!Also check out Dr. Reid's regular contributions to Psychology Today: Think Like a Shrink**********************Seeking a mental health provider? Try Psychology TodayNational Suicide Prevention Lifeline: 1-800-273-8255SAMHSA's National Helpline - 1-800-662-HELP (4357)-a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for individuals and families facing mental and/or substance use disorders.Thank you to Brendan Callahan for the original music featured on the podcast.Disclaimer:The information and other content provided on this podcast or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. All content, including text, graphics, images and information, contained on or available through this website is for general information purposes only.If you or any other person has a medical concern, you should consult with your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that have read on this website, blog or in any linked materials. If you think you may have a medical emergency, call your doctor or emergency services (911) immediately. You can also access th

Depression and anxiety disorders are rising, affecting more than fifty-eight million people in the United States alone. Many rely on therapy and medications to alleviate symptoms, but often this is not enough. The latest scientific advances in neuroscience and nutrition, along with our understanding of the mind-gut connection, have proven that how and what we eat greatly affects how we feel—physically, cognitively, and emotionally.Drew Ramsey, MD @DrewRamseyMD is a psychiatrist, author, and farmer. His work focuses on clinical excellence, nutritional interventions and creative media. He is an assistant clinical professor of psychiatry at Columbia University College of Physicians and Surgeons and in active telemedicine clinical practice based in New York City.His work has been featured by The New York Times, The Wall Street Journal, Lancet Psychiatry, The Today Show, BBC, and NPR and he has given three TEDx talks. He is the co-author of the Antidepressant Food Scale and his e-courses on Nutritional Psychiatry education for the public and clinicians. His books Eat to Beat Depression and Anxiety (Harperwave 2021), Eat Complete, 50 Shades of Kale, and The Happiness Diet explore the connections between mental health and nutrition. He is on the Advisory Board at Men's Health, the Editorial Board at Medscape Psychiatry, and is a member of the Well+Good Wellness Council.Get Eat To Beat Depression & Anxiety Here:Amazon US Amazon AUS Support this show http://supporter.acast.com/thestorybox. See acast.com/privacy for privacy and opt-out information.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers psychedelic-assisted psychotherapy with Dr Emma Hapke and Dr Daniel Rosenbaum, both of whom are psychiatrists at the University Health Network in Toronto and co-founders of UHN's Nikean Psychedelic Psychotherapy Research Centre (in addition to being lecturers in the Department of Psychiatry at the University of Toronto).   The learning objectives for this episode are as follows:   By the end of this episode, you should be able to… Briefly describe the history of psychedelics in psychiatry List the four classes of psychedelic drugs and their mechanism of action Summarize the evidence regarding psychedelic-assisted psychotherapy for various psychiatric disorders Discuss patient selection considerations for psychedelic-assisted psychotherapy Describe the safety, tolerability and possible side effects of psychedelic-assisted psychotherapy Understand how a psychedelic-assisted psychotherapy session is practically carried out   Guests: Dr Emma Hapke and Dr Daniel Rosenbaum   Hosts: Dr Chase Thompson (PGY4), Dr Nikhita Singhal (PGY3), Jake Johnston (CC4), and Annie Yu (CC4)   Audio editing by: Nikhita Singhal   Show notes by: Nikhita Singhal   Interview Content: Introduction - 0:00 Learning objectives - 02:47 Definitions/categories of psychedelics - 03:24 Classic psychedelics - 04:15 Empathogens (e.g. MDMA) - 07:15 Etymology of the term “psychedelic” - 09:30 Ketamine - 12:24 Iboga - 13:28 Brief history of psychedelic medicine - 17:51 Current evidence and ongoing trials - 27:38 MDMA and PTSD - 29:26 Psilocybin and treatment-resistant depression - 32:24 A word of caution - 34:29 End-of-life care - 38:47 Practical aspects of psychedelic-assisted psychotherapy sessions - 45:45 Safety considerations - 01:04:04 Future directions - 01:10:33 Closing comments - 01:19:07   Resources: Books: How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence (Michael Pollan) The Doors of Perception (Aldous Huxley) The Human Encounter With Death (Stanislav Grof and Joan Halifax) Brainwashed podcast series (CBC): https://www.cbc.ca/listen/cbc-podcasts/440-brainwashed Zendo Project (psychedelic peer support): https://zendoproject.org Nikean Psychedelic Psychotherapy Research Centre: https://www.uhn.ca/MentalHealth/Research/Nikean-Psychedelic-Psychotherapy-Research-Centre California Institute of Integral Studies (CIIS): https://www.ciis.edu Multidisciplinary Association for Psychedelic Studies (MAPS): https://maps.org PsychEd Episode 27 - Serotonin Pharmacology: From SSRIs to Psychedelics with Dr Robin Carhart-Harris) PsychEd Episode 34 - Ketamine for Treatment-Resistant Depression with Dr Sandhya Prashad   References: Carhart-Harris R, Giribaldi B, Watts R, et al. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021;384(15):1402-1411. https://doi.org/10.1056/nejmoa2032994 Carhart-Harris R, Nutt D. Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology. 2017;31(9):1091-1120. https://doi.org/10.1177/0269881117725915 Davis AK, Barrett FS, May DG, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(5):481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285 Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181-1197. dhttps://dx.doi.org/10.1177%2F0269881116675513 Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol. 2018;32(1):49-69. https://doi.org/10.1177/0269881117731279 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacol Ther. 2019;197:83-102. https://doi.org/10.1016/j.pharmthera.2018.11.010 Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27(6):1025-1033. https://doi.org/10.1038/s41591-021-01336-3 Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018;5(6):486-497. https://doi.org/10.1016/s2215-0366(18)30135-4 Nicholas CR, Henriquez KM, Gassman MC, et al. High dose psilocybin is associated with positive subjective effects in healthy volunteers. J Psychopharmacol. 2018;32(7):770-778. https://doi.org/10.1177/0269881118780713 Reiff CM, Richman EE, Nemeroff CB, et al. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020;177(5):391-410. https://doi.org/10.1176/appi.ajp.2019.19010035 Rosenbaum D, Boyle AB, Rosenblum AM, Ziai S, Chasen MR, Med MP. Psychedelics for psychological and existential distress in palliative and cancer care. Curr Oncol. 2019;26(4):225-226. https://dx.doi.org/10.3747%2Fco.26.5009 Swift TC, Belser AB, Agin-Liebes G, et al. Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress. Journal of Humanistic Psychology. 2017;57(5):488-519. https://doi.org/10.1177/0022167817715966   CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.   For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.

It's episode four of season four, and our first 'non-special' episode of the season. Mazz looks into the rationale behind routine prolactin monitoring, Shakira talks to us about the evidence behind psychosocial interventions in Schizophrenia, and Alanna takes us for a walk down the intestinal tract to look at different types of gut microbes.The references for this episode are:- Mazz: Jones, A. et al. Prolactin ordering patterns in psychiatric inpatients and the impact this has on patient management. Australasian Psychiatry, 2021. Vol 29 (3), pp 282-285.- Shakira: Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis. Bighelli, Irene et al. The Lancet Psychiatry, Volume 8, Issue 11, 969 - 980- Alanna: Nikolova VL, Smith MRB, Hall LJ, Cleare AJ, Stone JM, Young AH. Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis. JAMA Psychiatry. Published online September 15, 2021. doi:10.1001/jamapsychiatry.2021.2573The Psych Review was brought to you by Call to Mind, a telepsychiatry service that you can learn more about at www.calltomind.com.au. The original music in our podcast was provided by the very talented John Badgery, and our logo was designed by the creative genius of Naz.

Sources used in this episode.SOURCE [02:17] NBC News on FDA of mix and match vaccines - https://www.nbcnews.com/health/health-news/fda-oks-moderna-jj-boosters-mix-match-approach-rcna3191SOURCE [03:32] - Body of evidence 70 - https://bodyofevidence.ca/070-car-safety-and-the-astrazeneca-sagaSOURCE [03:32] - The Lancet Psychiatry on long term covid effects - https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00084-5/fulltextSOURCE [05:09]  - World Info Meters worldwide deaths - https://www.worldometers.info/coronavirus/SPONSOR [07:58] ABK Kustomz, use code "evidence" for 10% off - https://www.abkkustomz.com/SOURCE [8:29] Some more serious self help advice about not being pulled down - https://impossiblehq.com/crabs-in-a-bucket/SOURCE [8:29] Urban dictionary Crabs in a bucket - https://www.urbandictionary.com/define.php?term=Crabs%20in%20a%20BucketSOURCE [13:12] Majority of Americans say unions are positive for the country - https://www.pewresearch.org/fact-tank/2021/09/03/majorities-of-americans-say-unions-have-a-positive-effect-on-u-s-and-that-decline-in-union-membership-is-bad/SOURCE [15:23] Heritage Foundations take on unions - https://www.heritage.org/jobs-and-labor/commentary/biden-wants-more-unionization-do-american-workersSOURCE [19:40] Michigan's Right-to-Work Law Led to Huge Drop in Union Membership - https://www.mackinac.org/michigans-right-to-work-law-led-to-huge-drop-in-union-membershipSOURCE [21:24] Union voted down at Volkswagon - https://www.reuters.com/article/us-volkswagen-union-vote/vws-tennessee-workers-vote-against-union-representation-idUSKCN1TG014SOURCE [21:24] Union voted down at Nissan - https://www.reuters.com/article/us-uaw-mississippi-nissan/nissan-mississippi-workers-vote-heavily-against-unionization-idUSKBN1AL02OSOURCE [28:44] The Authoritarian Instincts of Police Unions - https://www.theatlantic.com/magazine/archive/2021/07/bust-the-police-unions/619006/SOURCE [29:46] David Sklansky, Stanford Law professor and author of Democracy and the Police - https://bookshop.org/a/12476/9780804755641SOURCE [31:25] Sam Walker, UNO, Police Unions increase violence - https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3813635SOURCE [37:02] Statista has simple stats about the amount of workers on strike - https://www.statista.com/chart/19407/number-of-striking-workers-in-the-us-per-year/SOURCE [37:32] According to the Economic Policy institute the 80s are also when worker productivity and earnings diverged - https://www.epi.org/productivity-pay-gap/SOURCE [39:56] Executive pay from Harvard Law - https://corpgov.law.harvard.edu/2021/01/29/sp-500-ceo-compensation-increase-trends-4/SOURCE [44:44] AP News strike hub - https://apnews.com/hub/strikesSOURCE [46:30] John Deere Executive pay - https://www1.salary.com/DEERE-and-CO-Executive-Salaries.htmlSOURCE [46:30] Kellogg's Executive pay - https://www1.salary.com/KELLOGG-CO-Executive-Salaries.htmlBULLSHIT SOURCE [46:54] Kellogg's Myth propaganda - https://kelloggsnegotiations.com/wp-content/uploads/2021/10/MythvsFact-2021.10.pdfBULLSHIT SOURCE [1:02:50] Kellogg's Propaganda website - https://kelloggsnegotiations.com/ ★ Support this podcast on Patreon ★

This week, Peter Simons covers a BMJ story that concluded 20% of health research is fraudulent, as well as a Lancet Psychiatry piece that critiques the research on long-acting injectable antipsychotics and debunks the claim that they are better than regular oral antipsychotics. BMJ: 20% of Health Research Is Fraudulent Researchers Debate Benefits of Long-Acting Injectable Antipsychotics  

Dr. Drew Ramsey, MD is a psychiatrist, author, and farmer. His work focuses on clinical excellence, nutritional interventions, and creative media. He is an assistant clinical professor of psychiatry at Columbia University College of Physicians and Surgeons and in active telemedicine clinical practice based in New York City. His work has been featured by The New York Times, The Wall Street Journal, Lancet Psychiatry, The Today Show, BBC, and NPR and he has given three TEDx talks. He is the co-author of the Antidepressant Food Scale and his e-courses on Nutritional Psychiatry education for the public and clinicians. His books Eat to Beat Depression and Anxiety (Harperwave 2021), Eat Complete, 50 Shades of Kale, and The Happiness Diet explore the connections between mental health and nutrition. He is on the Advisory Board at Men's Health, the Editorial Board at Medscape Psychiatry, and is a member of the Well+Good Wellness Council. He splits his time between New York City and Crawford County, Indiana where he lives with his wife and children on their organic farm and forest. We also chat about...  What nutritional psychiatry is  How Drew stumbled into nutritional psychiatry  The only time in traditional psychiatry when food is discussed  The four ways food impacts mental health  Food in institutions and schools  The role food plays in ADHD  Where to begin if you want to use food to improve your mental health  Why some people might say hummus is bad  Specific foods to help improve anxiety  How much fish we should be eating  Ways to spice up your veggies   Drews thoughts on alcohol and caffeine  ____________________________ ALL THE GOODIES FROM THIS EPISODE: I'm excited to announce that I'm now taking clients for 1:1 anxiety coaching. To join my client waitlist, send me a DM saying “I want to know more.” Coaching is on a first-come-first-serve basis currently. Click here if you're dying to learn more. ____________________________ COURAGEOUSLY.U SHOW NOTES:  https://courageouslyu.com/drew-ramsey/   COURAGEOUSLY.U FACEBOOK COMMUNITY: https://www.facebook.com/groups/1416219115169393   COURAGEOUSLY.U INSTAGRAM: https://www.instagram.com/courageously.u/  

Mental Health and Covid; Claudia examines a large new Lancet Psychiatry study showing that one in three people develop anxiety, depression or a neurological problem in the six months after they were ill with the virus. Ten years on from the Fukushima nuclear power plant disaster in Japan. Professor Jun Shigemura discusses whether the unseen threat of exposure to radiation can teach us anything about dealing with the hidden threat of the current Covid-19 virus. A report from Nigeria on how some people with fractures may turn to the traditional bonesetter to get their bones mended. Charles Mgbolu reports from Lagos. And diagnosing concussion: how a team at the University of Birmingham in the UK has developed a saliva test which can detect whether someone with a bang on the head during sport can safely return to the game. Professor Tony Belli explains the science behind the test. Plus Claudia's studio guest is Graham Easton, Professor of Clinical Communication Skills at Barts and the London Medical School. Presenter: Claudia Hammond Producer: Erika Wright (Picture: A traditional Japanese kite, bearing messages of hope by children living in Fukushima prefecture, is flown over the Great East Japan Earthquake and Nuclear Disaster Memorial Museum in Futaba town on the eve of the 10th anniversary of the disaster. Photo credit: Kazuhiro Nogi/AFP/Getty Images.)

Tania Glyde (they/she) is a psychotherapist in private practice in London, specialising in working with Gender, Sex and Relationship Diverse clients, offering both individual and relationship therapy. In 2014 they founded the London Gender, Sex and Relationship Diversity Practice. They trained as a somatic sexologist in 2017. ‘Although my private practice is talk-only, the opportunity to learn in a somatic environment has been invaluable when working on sexual issues with clients. It has also contributed to making my practice more trauma-informed.' Tania has published three books and has written for the Lancet and Lancet Psychiatry. They have recently published a paper about the LGBTQ+ experience of menopause: How can Therapists and Other Healthcare Practitioners Best Support and Validate their Queer Menopausal Clients? They will be speaking about their research at various conferences and events in 2021. Londoncentralcounselling.com queermenopause.com researchgate.net/profile/Tania_Glyde Instagram: @queermenopause Twitter: @tania_glyde

Drew Ramsey, M.D. is a psychiatrist, author, and farmer. He is a clear voice in the mental health conversation and one of psychiatry's leading proponents of using nutritional interventions. He is an assistant clinical professor of psychiatry at Columbia University College of Physicians and Surgeons.  He founded the Brain Food Clinic in New York City, offering treatment and consultation for depression, anxiety and emotional wellness concerns. His media work includes three recent TEDx talks, a video series with Big Think, and the BBC documentary Food on the Brain. His work and writing have been featured by The New York Times, The Wall Street Journal, The Huffington Post, Atlantic.com, Prevention, Lancet Psychiatry, and NPR, which named him a “kale evangelist.” He is the author of three books, most recently the award-winning cookbook Eat Complete: The 21 Nutrients that Fuel Brain Power, Boost Weight Loss and Transform Your Health (HarperWave 2016). Dr. Ramsey is a diplomate of the American Board of Psychiatry and Neurology. Drew Ramsey's new book, Eat to Beat Depression and Anxiety, found here: https://amzn.to/3bYsi98 Follow us @MedicineExplained on TikTok, @Medicine.Explained on IG. For inquiries: ContactMedicineExplained@gmail.com

Please reach out if you ever feel overwhelmed and in need of support by emailing me directly at info@stephaniedekker.orgAll additional contact information can be found at www.stephaniedekker.org or Instagram @stephaniedekker.counsellingThe content of this podcast is for information and entertainment purposes only. If you feel triggered by any information shared, please reach out to a health care professional. ReferencesBrooks, J. & Jackson, D. (2020). Older people and COVID-19: Isolation, risk and ageism. Journal of Clinical Nursing, 29(13-14), 2044-2046.Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., and Greenberg, N. (2020). The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet, 395, 912–920. doi: 10.1016/S0140-6736(20)30460-8Bzdok, D., and Dunbar, R. I. M. (2020). The neurobiology of social distance. Trends in Cognitive Science. doi: 10.1016/j.tics.2020.05.016Denham, J. (2020, May 2). For introverts, lockdown is a chance to play to our strengths. The Guardian, Retrieved from https://www.theguardian.com/lifeandstyle/2020/may/02/for-introverts-lockdown-is-a-chance-to-play-to-our-strengthsMatia, T., Dominski, F. H. & Marks, D. F. (2020). Human needs in COVID-19 isolation. Journal of Health Psychology, 25(7), 871-882.Novotney, A. (2019). The risks of social isolation. Monitor on Psychology, 50(5), 32.Pancani, L., Marinucci, M., Aureli, N., & Riva, P. (2020, April 5). Forced social isolation and mental health: A study on 1006 Italians under COVID-19 lockdown. https://doi.org/10.31234/osf.io/uacfjPietrabissa, G. & Simpson, S. G. (2020) Psychological Consequences of Social Isolation During COVID-19 Outbreak. Frontiers in Psychology, 11, 2201. Provenzi, L. & Tronick, E. (2020). The power of disconnection during the COVID-19 emergency: From isolation to reparation, Psychological Trauma: Theory, Research, Practice, and Policy, 12(1), S252-S254. Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., et al. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry, 7, 611–627. doi: 10.1016/S2215-0366(20)30203-0Saltzman, L. Y., Hansel, T. C., & Bordnick, P. S. (2020). Loneliness, isolation, and social support factors in psot-COVID-19 mental health, Psychological Trauma: Theory, Research, Practice, and Policy, 12(S1), 55-57. Sandford, A (2020) Coronavirus: Half of humanity now on lockdown as 90 countries call for confinement. Available at: https: //www.euronews.com/2020/04/02/coronavirus-in-europe-spain-s-death-toll-hits-10-000-after-record-950-new-deaths-in-24-hou

Professor Felice Jacka is Director of the Food & Mood Centre at Deakin University and an international leader in the transformative field of Nutritional Psychiatry research. She is also founder and president of the International Society for Nutritional Psychiatry Research (ISNPR) and immediate past president of the Australian Alliance for the Prevention of Mental Disorders. She has been responsible for the development of a highly innovative field of research establishing diet and nutrition as of importance to common mental disorders. These include the first studies to document a role for diet in adolescent depression, the first study to identify both maternal and early life nutrition as important predictors of children's mental health, and the first trial to show that dietary improvement can address depression. The results of the studies she has conducted have been highly influential Professor Jacka's current research focuses closely on the links between diet, gut health, and mental and brain health. Professor Jacka has published >160 peer-reviewed scientific papers, the majority in high-impact journals in the mental health field including the American Journal of Psychiatry, BMC Medicine and Lancet Psychiatry. She is listed in the top ten most highly-cited researchers in mood disorders in Australia (Scopus). She has written a book for the lay public called ‘Brain Changer', which we HIGHLY recommend. She is also passionate about prompting changes by policy-makers to improve the global food environment.

The paper we discuss in this episode is V Popova et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined with a Newly Initiated Oral Antidepressant in Treatment Resistant Depression: A Randomized Double-Blind Active-Controlled Study. Am J Psychiatry  2019; 176(6): 428-438.For a deeper understanding of the factors that contribute to placebo response, check out  BR Rutherford and SP Roose. A Model of Placebo Response in Antidepressant Clinical Trials. Am J  Psychiatry  2013; 170:723-733.Lots of data about the placebo response in antidepressant clinical trials:BT Walsh et al. Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing. JAMA 2002; 287(14):1840-1847.W Rief et al . Meta-analysis of the Placebo Response in Antidepressant Trials. Journal of Affective Disorders 2009; 118:1-8.TA Furukawa et al. Placebo Response Rates in Antidepressant Trials: A Systematic Review of Published and Unpublished Double-Blind Randomised Controlled Studies. Lancet Psychiatry 2016; 3:1059-1066.     

UMSOM class of 2015 alum and psychiatrist Dr. Melissa Shepard sits down with Dr. Neda Frayha for some real talk on the mental health challenges facing health care workers in the COVID-19 pandemic, and some concrete, tangible tools to help us get through this period. Spoiler alert: it's more than yoga. This conversation originally aired on Hippo Education's podcasts.  Resources: Free mental health crisis line for physicians impacted by Covid-19 related issues, staffed by US Psychiatrists (support only, cannot prescribe medications). 1-888-409-0141. www.physiciansupportline.com  COVID-19 Resource and Information Guide. National Alliance on Mental Illness. https://www.nami.org/getattachment/About-NAMI/NAMI-News/2020/NAMI-Updates-on-the-Coronavirus/COVID-19-Updated-Guide-1.pdf  Mental Health America, Mental Health And COVID-19 – Information And Resources Darnall B. The COVID-19 Wellness and Coping Toolkit: 11 Tips for Health Care Workers, Patients, and the Public. Psychology Today, 31 March 2020. https://www.psychologytoday.com/us/blog/empowered-relief/202003/the-covid-19-wellness-and-coping-toolkit    Good Therapy. https://www.goodtherapy.org  Psychology Today, Find a Therapist. Doxy.me Physician Support Line. https://doxy.me/physiciansupportline  Free access to Headspace Plus app (guided meditations) for healthcare professionals. https://www.headspace.com/health-covid-19 Center for Mind-Body Medicine at Georgetown. Introduction to evidenced-based techniques for helping people through and after trauma (things like guided imagery, body scans, breathing techniques) https://cmbm.org/thetransformation/resources/   References: Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976. doi:10.1001/jamanetworkopen.2020.3976   Chen QC, Liang M, Li Y, et al. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry 2020; 7(4):E15-16. doi:https://doi.org/10.1016/S2215-0366(20)30078-X   Garfin DR, Silver RC, Holman EA. The novel coronavirus (COVID-2019) outbreak: Amplification of public health consequences by media exposure. Health Psychology. 2020 May;39(5): 355-357. Advance online publication. doi: https://doi.org/10.1037/hea0000875   Rosenberg AR. Cultivating deliberate resilience during the coronavirus disease 2019 pandemic. JAMA Pediatr. Published online April 14, 2020. doi:10.1001/jamapediatrics.2020.1436   Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. Published online April 10, 2020. doi:10.1001/jamainternmed.2020.1562   Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med. Published online April 13, 2020. doi: 10.1056/NEJMp2008017

Do you or a loved one suffer from Bipolar Disorder?  This is Judy Gaman and this is your Stay Young Medical Minute.  According to the World Health Organization, 60 million people worldwide are affected by bipolar disorder.  The disorder causes manic and depressive episodes.  During manic episodes, a person can feel like they have unlimited energy and hardly sleep.  Depressive episodes are the opposite, a person has low to little energy and loses interest in day to day activities.  A new article published in The Lancet Psychiatry suggests that early care is key to helping people with bipolar disorder have a better quality of life.  People living with the disorder have a higher risk for self harm and suicide.  The earlier the treatment, the fewer relapses.  Talk to your doctor if you are experiencing symptoms of bipolar disorder.  This Stay Young Medical Minute is brought to you by Executive Medicine of Texas, a leader in preventative and proactive medicine. Learn why patients from around the globe trust Executive Medicine of Texas to their health. Visit EMTexas.com that's EMTexas.com. https://www.medicalnewstoday.com/articles/325565.php Thank you for listening to the Staying Young Medical Minute! With all the mixed messages on health, you need information that you can use and that you can trust. Listen in as the experts discuss all topics health related. It's time to STAY YOUNG and stay healthy! Each week we tackle a topic and often with leading scientists, best-selling authors, and even your favorite celebrities! As a listener of our show, your input is important to us. Please take a moment to fill out this quick survey so we can serve you better - https://survey.libsyn.com/stayingyoung2 For more information on The Staying Young Show, please visit our website at www.StayYoungAmerica.com, and subscribe to the show in iTunes, Stitcher, or your favorite podcast app. You can also reach out to our host, Judy Gaman on www.judygaman.com for book purchasing, and speaking opportunities in your area!